Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology 20150518
Title: The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
Journal: Leukemia 20150101
Title: Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Journal: PloS one 20140101
Title: ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Journal: Biochemical pharmacology 20130401
Title: A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia.
Journal: Cancer treatment reviews 20121201
Title: Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China.
Journal: Medical oncology (Northwood, London, England) 20121201
Title: Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101
Title: Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.
Journal: Leukemia & lymphoma 20121101
Title: [Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia].
Journal: Orvosi hetilap 20121014
Title: The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.
Journal: Investigational new drugs 20121001
Title: Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
Journal: Bone marrow transplantation 20121001
Title: Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity.
Journal: Bone marrow transplantation 20121001
Title: Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.
Journal: Leukemia & lymphoma 20121001
Title: N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.
Journal: Leukemia 20121001
Title: Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Journal: Journal of proteome research 20120907
Title: Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Journal: Medical oncology (Northwood, London, England) 20120901
Title: Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment.
Journal: Medical oncology (Northwood, London, England) 20120901
Title: Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
Journal: Bone marrow transplantation 20120901
Title: Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival.
Journal: Bone marrow transplantation 20120901
Title: A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
Journal: Bone marrow transplantation 20120901
Title: Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
Journal: Leukemia & lymphoma 20120901
Title: Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120901
Title: Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.
Journal: Haematologica 20120901
Title: A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
Journal: Annals of hematology 20120901
Title: Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma.
Journal: American journal of hematology 20120901
Title: Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.
Journal: Leukemia research 20120901
Title: Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Journal: Pediatric hematology and oncology 20120901
Title: Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation.
Journal: Cancer 20120815
Title: ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.
Journal: Blood 20120809
Title: Treatment of older patients with mantle-cell lymphoma.
Journal: The New England journal of medicine 20120809
Title: Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.
Journal: Leukemia & lymphoma 20120801
Title: Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Journal: Clinical lymphoma, myeloma & leukemia 20120801
Title: Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120801
Title: Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak.
Journal: Cell death & disease 20120801
Title: Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
Journal: Blood 20120712
Title: Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710
Title: [Modern times: back to past, back to future].
Journal: Medicina clinica 20120707
Title: The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.
Journal: Leukemia & lymphoma 20120701
Title: Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
Journal: Leukemia & lymphoma 20120701
Title: Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701
Title: Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Journal: Annals of hematology 20120701
Title: Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study.
Journal: Journal of cancer research and clinical oncology 20120701
Title: Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Journal: Biochemical pharmacology 20120701
Title: Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701
Title: miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Journal: Carcinogenesis 20120701
Title: Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia.
Journal: Die Pharmazie 20120701
Title: T-cell large granular lymphocytic leukemia: treatment experience with fludarabine.
Journal: Clinics (Sao Paulo, Brazil) 20120701
Title: Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia.
Journal: Gene 20120615
Title: A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia.
Journal: Investigational new drugs 20120601
Title: Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601
Title: Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.
Journal: Haematologica 20120601
Title: Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Journal: Haematologica 20120601
Title: Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
Journal: Pediatric transplantation 20120601
Title: T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.
Journal: British journal of haematology 20120601
Title: Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
Journal: American journal of hematology 20120601
Title: Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53.
Journal: Proteomics. Clinical applications 20120601
Title: Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Journal: Blood 20120531
Title: Risk categories and refractory CLL in the era of chemoimmunotherapy.
Journal: Blood 20120503
Title: Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT.
Journal: Bone marrow transplantation 20120501
Title: Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20120501
Title: Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
Journal: Annals of hematology 20120501
Title: Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
Journal: Leukemia & lymphoma 20120501
Title: The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.
Journal: Leukemia & lymphoma 20120501
Title: Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.
Journal: Leukemia & lymphoma 20120501
Title: Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia.
Journal: Leukemia 20120501
Title: Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20120501
Title: Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20120501
Title: The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Journal: Bone marrow transplantation 20120501
Title: Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
Journal: Blood reviews 20120501
Title: The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.
Journal: Oncotarget 20120501
Title: Fludarabine may overcome resistance to rituximab in IgM-related neuropathy.
Journal: Journal of the neurological sciences 20120415
Title: Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20120401
Title: The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401
Title: LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism.
Journal: Leukemia research 20120401
Title: Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120401
Title: FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
Journal: Journal of pediatric hematology/oncology 20120401
Title: Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia.
Journal: Blood 20120329
Title: Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Journal: Blood 20120322
Title: Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320
Title: Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120310
Title: Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning.
Journal: Bone marrow transplantation 20120301
Title: FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
Journal: Hematological oncology 20120301
Title: The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study.
Journal: Hematological oncology 20120301
Title: Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Journal: The British journal of nutrition 20120301
Title: Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages.
Journal: Pediatric transplantation 20120301
Title: Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Journal: Leukemia & lymphoma 20120301
Title: Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
Journal: Leukemia & lymphoma 20120301
Title: Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20120301
Title: Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20120301
Title: Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301
Title: Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.
Journal: Haematologica 20120301
Title: Fludarabine and rituximab for relapsed or refractory hairy cell leukemia.
Journal: Blood 20120301
Title: Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
Journal: American journal of hematology 20120301
Title: Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120301
Title: Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.
Journal: Nature cell biology 20120301
Title: Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy.
Journal: The Korean journal of internal medicine 20120301
Title: [Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20120301
Title: Alemtuzumab for patients with chronic lymphocytic leukaemia.
Journal: The Cochrane database of systematic reviews 20120215
Title: Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.
Journal: Bone marrow transplantation 20120201
Title: Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation.
Journal: Bone marrow transplantation 20120201
Title: A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120201
Title: Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility.
Journal: Annals of hematology 20120201
Title: Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201
Title: Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.
Journal: Cancer chemotherapy and pharmacology 20120201
Title: Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20120201
Title: Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20120201
Title: Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44.
Journal: Journal of clinical immunology 20120201
Title: CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.
Journal: Haematologica 20120201
Title: Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders.
Journal: Clinical lymphoma, myeloma & leukemia 20120201
Title: Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201
Title: Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20120201
Title: Individualized fludarabine-based regimen in elderly patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal: Advances in therapy 20120201
Title: Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.
Journal: The Journal of biological chemistry 20120120
Title: Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
Journal: Cancer 20120115
Title: Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
Title: Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
Title: Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.
Journal: Bone marrow transplantation 20120101
Title: Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Journal: Bone marrow transplantation 20120101
Title: Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.
Journal: Leukemia & lymphoma 20120101
Title: Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials.
Journal: Leukemia & lymphoma 20120101
Title: Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20120101
Title: FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
Journal: American journal of hematology 20120101
Title: Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine.
Journal: European journal of haematology 20120101
Title: Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides.
Journal: European journal of medicinal chemistry 20120101
Title: Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning?
Journal: Clinical transplantation 20120101
Title: The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
Journal: PloS one 20120101
Title: Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study.
Journal: Pharmacological reports : PR 20120101
Title: Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine.
Journal: Journal of clinical and experimental hematopathology : JCEH 20120101
Title: Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma.
Journal: BMJ case reports 20120101
Title: Successful treatment of γ-heavy-chain disease with rituximab and fludarabine.
Journal: Acta haematologica 20120101
Title: Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Journal: Blood 20111222
Title: Chemotherapy: New FluCam combination therapy has familiar limitations.
Journal: Nature reviews. Clinical oncology 20111206
Title: Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID.
Journal: Bone marrow transplantation 20111201
Title: Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.
Journal: Bone marrow transplantation 20111201
Title: Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Journal: Hematological oncology 20111201
Title: Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
Journal: Scandinavian journal of urology and nephrology 20111201
Title: Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia 20111201
Title: IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
Journal: The Journal of investigative dermatology 20111201
Title: Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two?
Journal: Leukemia & lymphoma 20111201
Title: A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia 20111201
Title: Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment.
Journal: Leukemia & lymphoma 20111201
Title: The effects of chemotherapeutic agents on differentiated chordoma cells.
Journal: Journal of neurosurgery. Spine 20111201
Title: Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.
Journal: The Lancet. Oncology 20111201
Title: Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
Journal: The American Journal of dermatopathology 20111201
Title: Fludarabine nucleoside modulates nuclear 'survival and death' proteins in resistant chronic lymphocytic leukemia cells.
Journal: Nucleosides, nucleotides & nucleic acids 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient.
Journal: Experimental oncology 20111201
Title: Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20111201
Title: Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Journal: Cancer 20111115
Title: Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study.
Journal: Blood 20111110
Title: Anti-CD20: tales of identical twins?
Journal: Blood 20111110
Title: Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
Journal: JAMA 20111102
Title: Overcoming the age barrier in hematopoietic stem cell transplantation: progress, but still a long way to go.
Journal: JAMA 20111102
Title: Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
Journal: International journal of radiation oncology, biology, physics 20111101
Title: Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes.
Journal: Bone marrow transplantation 20111101
Title: Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111101
Title: Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Journal: European journal of haematology 20111101
Title: Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.
Journal: Clinical immunology (Orlando, Fla.) 20111101
Title: Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.
Journal: Journal of medical virology 20111101
Title: Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Journal: Cytometry. Part B, Clinical cytometry 20111101
Title: Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
Journal: Clinical and experimental immunology 20111101
Title: Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Journal: Journal of pediatric surgery 20111101
Title: An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.
Journal: Blood 20111013
Title: Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4).
Journal: Bone marrow transplantation 20111001
Title: Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001
Title: Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001
Title: Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.
Journal: Annals of hematology 20111001
Title: Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.
Journal: Leukemia & lymphoma 20111001
Title: Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis.
Journal: Leukemia & lymphoma 20111001
Title: Treatment strategies in patients with core-binding factor acute myeloid leukemia.
Journal: Current oncology reports 20111001
Title: A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.
Journal: British journal of haematology 20111001
Title: Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir.
Journal: Cancer gene therapy 20111001
Title: Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia.
Journal: International journal of hematology 20111001
Title: Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
Journal: Blood 20110929
Title: Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Journal: Blood 20110922
Title: Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910
Title: A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Journal: Cancer chemotherapy and pharmacology 20110901
Title: Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
Title: Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
Title: Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Journal: Haematologica 20110901
Title: Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.
Journal: Blood 20110901
Title: Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
Journal: British journal of haematology 20110901
Title: Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial.
Journal: Expert review of anticancer therapy 20110901
Title: Comment on research report by Gruson and colleagues, this issue.
Journal: Journal of the peripheral nervous system : JPNS 20110901
Title: Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
Journal: Journal of the peripheral nervous system : JPNS 20110901
Title: Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.
Journal: Blood 20110825
Title: Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.
Journal: Blood 20110825
Title: Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia.
Journal: Blood 20110825
Title: Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG.
Journal: Bone marrow transplantation 20110801
Title: Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801
Title: NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801
Title: A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110801
Title: Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD).
Journal: Pediatric blood & cancer 20110801
Title: Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110801
Title: Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Journal: Cancer gene therapy 20110801
Title: Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis.
Journal: Leukemia research 20110801
Title: Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801
Title: Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110801
Title: [The comparison of fludarabine or antithymocyte globulin based non-myeloablative conditioning regimen for haematologic diseases with graft-versus-host disease].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110801
Title: ⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.
Journal: Blood 20110728
Title: Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110715
Title: Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.
Journal: British journal of cancer 20110712
Title: High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
Title: Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
Title: Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
Title: Unrelated donor transplantation for acute myelogenous leukemia in first remission.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
Title: Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma.
Journal: Annals of hematology 20110701
Title: Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy.
Journal: Leukemia research 20110701
Title: Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds.
Journal: Leukemia & lymphoma 20110701
Title: New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia.
Journal: American journal of hematology 20110701
Title: A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
Journal: British journal of haematology 20110701
Title: Rituximab in chronic lymphocytic leukemia.
Journal: Advances in therapy 20110701
Title: Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.
Journal: Blood 20110616
Title: [Practical considerations and questions in the treatment of chronic lymphocytic leukemia].
Journal: Orvosi hetilap 20110612
Title: A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.
Journal: Bone marrow transplantation 20110601
Title: Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
Title: Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
Title: Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
Title: CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Journal: Leukemia research 20110601
Title: STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion.
Journal: American journal of physiology. Cell physiology 20110601
Title: Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
Journal: Cancer gene therapy 20110601
Title: Purine analog toxicity in patients with hairy cell leukemia.
Journal: Leukemia & lymphoma 20110601
Title: Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601
Title: Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.
Journal: American journal of hematology 20110601
Title: Allogeneic stem cell transplantation in follicular lymphoma.
Journal: Best practice & research. Clinical haematology 20110601
Title: Fludarabine versus chlorambucil: is the debate over?
Journal: Clinical lymphoma, myeloma & leukemia 20110601
Title: Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110515
Title: Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
Journal: Cancer 20110515
Title: Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement.
Journal: International journal of radiation oncology, biology, physics 20110501
Title: Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia.
Journal: International journal of cancer 20110501
Title: Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases.
Journal: Bone marrow transplantation 20110501
Title: EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT.
Journal: Bone marrow transplantation 20110501
Title: Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.
Journal: Bone marrow transplantation 20110501
Title: Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT.
Journal: Bone marrow transplantation 20110501
Title: Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity.
Journal: Bone marrow transplantation 20110501
Title: Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
Title: Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
Title: Diagnostic and therapeutic challenges.
Journal: Retina (Philadelphia, Pa.) 20110501
Title: The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
Title: EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab.
Journal: Journal of neurology 20110501
Title: [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Journal: Actas dermo-sifiliograficas 20110501
Title: How I manage cold agglutinin disease.
Journal: British journal of haematology 20110501
Title: Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia.
Journal: Haematologica 20110501
Title: Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20110501
Title: Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
Journal: American journal of hematology 20110501
Title: Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK.
Journal: Health technology assessment (Winchester, England) 20110501
Title: Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20110401
Title: Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
Journal: Leukemia research 20110401
Title: Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients.
Journal: Leukemia research 20110401
Title: Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20110401
Title: Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401
Title: Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation.
Journal: International journal of hematology 20110401
Title: Inhibitory effect of leptin on rosiglitazone-induced differentiation of primary adipocytes prepared from TallyHO/Jng mice.
Journal: Biochemical and biophysical research communications 20110325
Title: Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.
Journal: Blood 20110317
Title: Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
Journal: Journal of proteome research 20110304
Title: Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301
Title: Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301
Title: Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Journal: Annals of hematology 20110301
Title: APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.
Journal: European journal of haematology 20110301
Title: Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.
Journal: Biochemical pharmacology 20110301
Title: A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
Journal: British journal of haematology 20110301
Title: Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Journal: Leukemia & lymphoma 20110301
Title: Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Journal: Journal of pediatric hematology/oncology 20110301
Title: Early initial therapy of advanced follicular lymphoma: the need for vigilance.
Journal: Leukemia & lymphoma 20110301
Title: Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors.
Journal: Journal of the National Cancer Institute 20110216
Title: ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
Journal: Oncogene 20110210
Title: Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
Journal: Annals of hematology 20110201
Title: Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Journal: Haematologica 20110201
Title: Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20110201
Title: The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells.
Journal: Oligonucleotides 20110201
Title: Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications.
Journal: International journal of hematology 20110201
Title: Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning.
Journal: Leukemia & lymphoma 20110201
Title: Personalizing treatment for chronic lymphocytic leukemia.
Journal: Expert review of hematology 20110201
Title: Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.
Journal: Expert review of anticancer therapy 20110201
Title: [A preliminary study on efficacy of allogeneic hematopoietic stem cell transplantation by myeloablative conditioning regimen with fludarabine for high risk leukemia patients].
Journal: Zhongguo shi yan xue ye xue za zhi 20110201
Title: [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110201
Title: The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.
Journal: Biochemical pharmacology 20110115
Title: Synthesis and biological properties of the cytotoxic 14-membered macrolides aspergillide A and B.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20110110
Title: Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies.
Journal: Blood 20110106
Title: Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
Journal: Bone marrow transplantation 20110101
Title: High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20110101
Title: Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.
Journal: Bone marrow transplantation 20110101
Title: Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101
Title: Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Journal: Annals of hematology 20110101
Title: Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Journal: Cancer immunology, immunotherapy : CII 20110101
Title: Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.
Journal: Leukemia & lymphoma 20110101
Title: Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Journal: Journal of medical microbiology 20110101
Title: U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.
Journal: The oncologist 20110101
Title: A transient IgE monoclonal protein in a child.
Journal: Annals of clinical biochemistry 20110101
Title: FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases.
Journal: Journal of experimental & clinical cancer research : CR 20110101
Title: [Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101
Title: Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
Journal: Journal of hematology & oncology 20110101
Title: [Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia].
Journal: Gaceta sanitaria 20110101
Title: Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.
Journal: BMC nephrology 20110101
Title: Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Journal: Neoplasma 20110101
Title: Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20110101
Title: Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma.
Journal: Clinical laboratory science : journal of the American Society for Medical Technology 20110101
Title: Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience.
Journal: International journal of immunopathology and pharmacology 20110101
Title: Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.
Journal: Hematology/oncology and stem cell therapy 20110101
Title: Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
Journal: Onkologie 20110101
Title: Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
Journal: PloS one 20110101
Title: The treatment of relapsed refractory chronic lymphocytic leukemia.
Journal: Hematology. American Society of Hematology. Education Program 20110101
Title: Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Journal: Lancet (London, England) 20101211
Title: CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.
Journal: Bone marrow transplantation 20101201
Title: Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.
Journal: Gene therapy 20101201
Title: Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Journal: Experimental hematology 20101201
Title: Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Journal: Human pathology 20101201
Title: Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
Journal: Leukemia & lymphoma 20101201
Title: Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
Journal: Leukemia & lymphoma 20101201
Title: Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.
Journal: Leukemia & lymphoma 20101201
Title: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Journal: Leukemia 20101201
Title: Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring.
Journal: Leukemia & lymphoma 20101201
Title: Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.
Journal: Hematological oncology 20101201
Title: The European Medicines Agency review of ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use.
Journal: The oncologist 20101201
Title: DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Journal: Experimental oncology 20101201
Title: [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Journal: Methods and findings in experimental and clinical pharmacology 20101201
Title: Effect of FCGR2A and FCGR3A variants on CLL outcome.
Journal: Blood 20101118
Title: Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
Journal: Annals of hematology 20101101
Title: Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Journal: The Journal of allergy and clinical immunology 20101101
Title: Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101
Title: B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.
Journal: Leukemia 20101101
Title: A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.
Journal: Leukemia 20101101
Title: Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Journal: Leukemia & lymphoma 20101101
Title: Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
Journal: Leukemia & lymphoma 20101101
Title: Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution.
Journal: American journal of hematology 20101101
Title: Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Journal: Transplantation proceedings 20101101
Title: Refractory chronic lymphocytic leukemia--new therapeutic strategies.
Journal: Oncotarget 20101101
Title: High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.
Journal: Blood 20101028
Title: Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.
Journal: Blood 20101021
Title: Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010
Title: TP53 mutation and survival in chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010
Title: Chronic lymphocytic leukaemia--moving towards cure?
Journal: Lancet (London, England) 20101002
Title: Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England) 20101002
Title: Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101001
Title: HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus.
Journal: Journal of hepatology 20101001
Title: Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.
Journal: Pediatric hematology and oncology 20101001
Title: The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.
Journal: British journal of haematology 20101001
Title: Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.
Journal: Leukemia & lymphoma 20101001
Title: Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia.
Journal: Leukemia 20101001
Title: Current immunochemotherapy strategies in follicular lymphoma.
Journal: Advances in therapy 20101001
Title: What's new in Waldenström macroglobulinemia.
Journal: Leukemia & lymphoma 20101001
Title: Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.
Journal: Leukemia & lymphoma 20101001
Title: Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Journal: Expert review of anticancer therapy 20101001
Title: The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
Journal: Health technology assessment (Winchester, England) 20101001
Title: Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20101001
Title: Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
Journal: Cancer 20100915
Title: Rapid vision loss associated with fludarabine administration.
Journal: Retina (Philadelphia, Pa.) 20100901
Title: U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100901
Title: Chemoimmunotherapy of chronic lymphocytic leukemia.
Journal: Nature reviews. Clinical oncology 20100901
Title: Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity.
Journal: European journal of medicinal chemistry 20100901
Title: LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells.
Journal: Leukemia 20100901
Title: Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
Journal: American journal of hematology 20100901
Title: Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901
Title: Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.
Journal: International journal of hematology 20100901
Title: Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.
Journal: British journal of cancer 20100824
Title: Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.
Journal: Blood 20100812
Title: Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
Journal: American journal of hematology 20100801
Title: Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Journal: Bone marrow transplantation 20100801
Title: High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
Journal: European journal of cancer (Oxford, England : 1990) 20100801
Title: Auer rod-like inclusions in a low-grade B-cell leukemia.
Journal: Annals of diagnostic pathology 20100801
Title: [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].
Journal: Orvosi hetilap 20100801
Title: Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL).
Journal: Clinical lymphoma, myeloma & leukemia 20100801
Title: [Bone marrow failure due to telomere associated gene mutation].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100801
Title: Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis.
Journal: Blood 20100729
Title: Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
Journal: European journal of pharmacology 20100725
Title: Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710
Title: Inhibition of STAT1 accelerates bone fracture healing.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100701
Title: Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
Journal: Leukemia research 20100701
Title: Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.
Journal: Cancer investigation 20100701
Title: Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
Journal: European journal of haematology 20100701
Title: Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia.
Journal: The American journal of the medical sciences 20100701
Title: Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.
Journal: Leukemia 20100701
Title: Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options.
Journal: Leukemia & lymphoma 20100701
Title: Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.
Journal: Environmental and molecular mutagenesis 20100701
Title: Ofatumumab in the treatment of chronic lymphocytic leukemia.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100701
Title: HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
Journal: Blood 20100624
Title: T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.
Journal: Medical oncology (Northwood, London, England) 20100601
Title: Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells.
Journal: Molecular and cellular biochemistry 20100601
Title: Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601
Title: Regulatory T cell as a target for cancer therapy.
Journal: Archivum immunologiae et therapiae experimentalis 20100601
Title: Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.
Journal: Haematologica 20100601
Title: Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
Journal: Muscle & nerve 20100601
Title: [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].
Journal: Zhongguo shi yan xue ye xue za zhi 20100601
Title: Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510
Title: Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants.
Journal: Bone marrow transplantation 20100501
Title: All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.
Journal: The Journal of biological chemistry 20100430
Title: Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410
Title: A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
Journal: Biomedical chromatography : BMC 20100401
Title: [Brucella bacteremia reactivation 70 years after the primary infection].
Journal: Medecine et maladies infectieuses 20100401
Title: Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients.
Journal: Leukemia research 20100401
Title: Keratotic vascular papules over the feet: a case of Waldenström's macroglobulinaemia-associated cutaneous macroglobulinosis.
Journal: Clinical and experimental dermatology 20100401
Title: The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100401
Title: Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.
Journal: American journal of hematology 20100401
Title: Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma.
Journal: American journal of hematology 20100401
Title: Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401
Title: Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401
Title: Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis.
Journal: American journal of hematology 20100401
Title: Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Journal: Journal of pediatric hematology/oncology 20100401
Title: Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.
Journal: The Journal of allergy and clinical immunology 20100401
Title: [Female case of successful engraftment after PBSCT from her HLA-haploidentical son for severe aplastic anemia during maintenance peritoneal dialysis].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100401
Title: Incidence and susceptibility to therapy-related myeloid neoplasms.
Journal: Chemico-biological interactions 20100319
Title: HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.
Journal: Bone marrow transplantation 20100301
Title: Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
Journal: Leukemia research 20100301
Title: Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
Journal: Bone marrow transplantation 20100301
Title: Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301
Title: The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Journal: European journal of haematology 20100301
Title: Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma.
Journal: British journal of haematology 20100301
Title: R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.
Journal: Leukemia 20100301
Title: CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
Journal: Experimental hematology 20100301
Title: Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.
Journal: Leukemia 20100301
Title: Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient.
Journal: International journal of hematology 20100301
Title: A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.
Journal: Leukemia & lymphoma 20100301
Title: Clinical and imaging features of fludarabine neurotoxicity.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20100301
Title: NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220
Title: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Journal: Blood 20100204
Title: Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma.
Journal: Pediatric transplantation 20100201
Title: Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.
Journal: Bone marrow transplantation 20100201
Title: Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine.
Journal: Bone marrow transplantation 20100201
Title: The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100201
Title: Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
Journal: British journal of haematology 20100201
Title: [Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20100201
Title: Drug-induced immune hemolytic anemia.
Journal: Clinical advances in hematology & oncology : H&O 20100201
Title: Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.
Journal: Blood 20100121
Title: Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100120
Title: Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation 20100101
Title: Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
Journal: Bone marrow transplantation 20100101
Title: Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20100101
Title: Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.
Journal: Leukemia 20100101
Title: Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.
Journal: Biopharmaceutics & drug disposition 20100101
Title: R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis.
Journal: Journal of cellular biochemistry 20100101
Title: Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
Journal: British journal of haematology 20100101
Title: Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activation in vitro.
Journal: Leukemia & lymphoma 20100101
Title: New agents for the treatment of genetically high-risk chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20100101
Title: Novel therapeutic approaches in systemic lupus erythematosus.
Journal: Frontiers in bioscience (Scholar edition) 20100101
Title: Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Journal: Dermatology (Basel, Switzerland) 20100101
Title: Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Journal: Acta haematologica 20100101
Title: Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab.
Journal: Chemotherapy 20100101
Title: A rare occurrence of hairy cell leukemia in the Thai population: a case report.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100101
Title: [Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia].
Journal: Terapevticheskii arkhiv 20100101
Title: Fludarabine-induced bradycardia in a patient with refractory leukemia.
Journal: Annals of Saudi medicine 20100101
Title: Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
Journal: Molecular cancer 20100101
Title: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
Journal: Molecular cancer 20100101
Title: Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
Journal: Human antibodies 20100101
Title: Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients.
Journal: Cell transplantation 20100101
Title: Use of clofarabine for acute childhood leukemia.
Journal: Biologics : targets & therapy 20100101
Title: Immune hemolytic anemia associated with drug therapy.
Journal: Blood reviews 20100101
Title: Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
Journal: Pathology 20100101
Title: Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.
Journal: Journal of hematology & oncology 20100101
Title: Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.
Journal: Acta haematologica 20100101
Title: Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.
Journal: Blood 20091224
Title: Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal: Blood 20091217
Title: Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Journal: Blood 20091217
Title: IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.
Journal: Annals of hematology 20091201
Title: Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
Journal: Bone marrow transplantation 20091201
Title: Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia.
Journal: Irish journal of medical science 20091201
Title: Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
Journal: British journal of haematology 20091201
Title: Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.
Journal: Journal of hepatology 20091201
Title: Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Journal: Leukemia & lymphoma 20091201
Title: [FLAG regimen as consolidation therapy for patients with acute myeloid leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20091201
Title: In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
Journal: Internal medicine journal 20091201
Title: Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Journal: Cancer 20091115
Title: Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2.
Journal: Bone marrow transplantation 20091101
Title: The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
Journal: Leukemia 20091101
Title: Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Journal: Experimental hematology 20091101
Title: 5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101
Title: Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
Journal: American journal of hematology 20091101
Title: Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
Title: Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
Title: The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
Journal: Cancer research 20091101
Title: Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101
Title: First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Journal: Blood 20091015
Title: Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
Journal: Cancer chemotherapy and pharmacology 20091001
Title: Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
Journal: Leukemia research 20091001
Title: Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Journal: Leukemia 20091001
Title: Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
Journal: Leukemia 20091001
Title: Diagnosis by sheer coincidence.
Journal: The international journal of cardiovascular imaging 20091001
Title: Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma.
Journal: Cancer science 20091001
Title: Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.
Journal: British journal of haematology 20091001
Title: Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
Journal: Pancreas 20091001
Title: Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival.
Journal: Leukemia & lymphoma 20091001
Title: FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Journal: American journal of hematology 20091001
Title: Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091001
Title: Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.
Journal: Leukemia & lymphoma 20091001
Title: The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial.
Journal: Leukemia & lymphoma 20091001
Title: [Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20091001
Title: [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
Journal: Zhongguo shi yan xue ye xue za zhi 20091001
Title: Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
Journal: Leukemia & lymphoma 20091001
Title: p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy.
Journal: Leukemia & lymphoma 20091001
Title: Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
Journal: Tennessee medicine : journal of the Tennessee Medical Association 20091001
Title: Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.
Journal: Blood 20090924
Title: Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
Journal: Lancet (London, England) 20090912
Title: Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Journal: Pediatric transplantation 20090901
Title: Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
Journal: Cancer 20090901
Title: Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
Journal: British journal of haematology 20090901
Title: Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901
Title: Rituximab for polyneuropathy with IgM monoclonal gammopathy.
Journal: Journal of neurology, neurosurgery, and psychiatry 20090901
Title: Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.
Journal: Haematologica 20090901
Title: Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
Journal: Blood 20090820
Title: Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820
Title: Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Journal: Leukemia research 20090801
Title: Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.
Journal: Leukemia & lymphoma 20090801
Title: Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide.
Journal: Annals of the New York Academy of Sciences 20090801
Title: [Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801
Title: [Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801
Title: Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090715
Title: Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures.
Journal: Leukemia research 20090701
Title: Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
Journal: Current opinion in hematology 20090701
Title: Treatment of fludarabine-refractory chronic lymphocytic leukemia.
Journal: Cancer 20090701
Title: Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Journal: Cancer research 20090701
Title: Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.
Journal: Journal of pediatric hematology/oncology 20090701
Title: Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.
Journal: Leukemia research 20090601
Title: The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions.
Journal: Bone marrow transplantation 20090601
Title: A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
Journal: British journal of haematology 20090601
Title: Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090601
Title: The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia.
Journal: Journal of Korean medical science 20090601
Title: [Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20090601
Title: Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
Journal: Current opinion in oncology 20090601
Title: Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
Journal: Health technology assessment (Winchester, England) 20090601
Title: Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen.
Journal: International journal of clinical oncology 20090601
Title: Pentostatin treatment combinations in chronic lymphocytic leukemia.
Journal: Clinical advances in hematology & oncology : H&O 20090601
Title: Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090601
Title: Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Journal: Bone marrow transplantation 20090501
Title: Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
Journal: Bone marrow transplantation 20090501
Title: Oxidative stress and delta-ALA-D activity in different conditioning regimens in allogeneic bone marrow transplantation patients.
Journal: Clinical biochemistry 20090501
Title: Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation.
Journal: Pediatric blood & cancer 20090501
Title: A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
Journal: Leukemia 20090501
Title: Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
Journal: Cancer 20090501
Title: Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
Journal: European journal of pharmacology 20090501
Title: Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20090501
Title: Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
Journal: Journal of clinical pathology 20090501
Title: Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
Journal: Blood 20090416
Title: Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens.
Journal: Blood 20090402
Title: Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
Journal: American journal of hematology 20090401
Title: Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20090401
Title: [IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20090401
Title: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
Journal: Internal medicine journal 20090401
Title: A single apheresis procedure in the donor may be enough to complete an allograft using the 'Mexican method' of non-ablative allografting.
Journal: Blood transfusion = Trasfusione del sangue 20090401
Title: Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.
Journal: Blood 20090319
Title: Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma.
Journal: Annals of hematology 20090301
Title: Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.
Journal: Leukemia 20090301
Title: Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Journal: Bone marrow transplantation 20090301
Title: HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling.
Journal: Microvascular research 20090301
Title: Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.
Journal: American journal of hematology 20090301
Title: Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Journal: American journal of hematology 20090301
Title: Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
Journal: Leukemia & lymphoma 20090301
Title: Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis.
Journal: Leukemia & lymphoma 20090301
Title: Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20090301
Title: Assessment of bone marrow response in Waldenström's macroglobulinemia.
Journal: Clinical lymphoma & myeloma 20090301
Title: Rituximab-based treatments in Waldenström's macroglobulinemia.
Journal: Clinical lymphoma & myeloma 20090301
Title: Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
Journal: Clinical lymphoma & myeloma 20090301
Title: A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.
Journal: Cancer chemotherapy and pharmacology 20090201
Title: Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
Journal: Leukemia research 20090201
Title: Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Journal: Annals of hematology 20090201
Title: Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro.
Journal: Journal of cancer research and clinical oncology 20090201
Title: Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.
Journal: Leukemia 20090201
Title: Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine.
Journal: European journal of haematology 20090201
Title: Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
Title: Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
Title: Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
Title: Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090201
Title: Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
Journal: Leukemia & lymphoma 20090201
Title: Alkylating agents for Waldenstrom's macroglobulinaemia.
Journal: The Cochrane database of systematic reviews 20090121
Title: Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120
Title: Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110
Title: Dasatinib induces a response in chronic lymphocytic leukemia.
Journal: Blood 20090108
Title: Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures.
Journal: Cancer chemotherapy and pharmacology 20090101
Title: A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia.
Journal: Annals of hematology 20090101
Title: Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Journal: Bone marrow transplantation 20090101
Title: AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.
Journal: Blood 20090101
Title: Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.
Journal: Immunologic research 20090101
Title: Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia.
Journal: Haematologica 20090101
Title: [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
Journal: Presse medicale (Paris, France : 1983) 20090101
Title: Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
Journal: British journal of haematology 20090101
Title: Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
Journal: British journal of haematology 20090101
Title: Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
Journal: International journal of radiation oncology, biology, physics 20090101
Title: Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
Title: Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
Title: A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
Title: Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.
Journal: Cytotherapy 20090101
Title: ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Journal: BMC cancer 20090101
Title: Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.
Journal: PloS one 20090101
Title: Chronic lymphocytic leukaemia: current first-line therapy.
Journal: Internal medicine journal 20090101
Title: Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections.
Journal: Clinical transplantation 20090101
Title: Fludarabine in the treatment of chronic lymphocytic leukemia: a review.
Journal: Therapeutics and clinical risk management 20090101
Title: FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Journal: Immunologic research 20090101
Title: Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101
Title: Update in the management of chronic lymphocytic leukemia.
Journal: Journal of hematology & oncology 20090101
Title: Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone.
Journal: Tumori 20090101
Title: Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Journal: Acta dermato-venereologica 20090101
Title: Immune hemolytic anemia--selected topics.
Journal: Hematology. American Society of Hematology. Education Program 20090101
Title: State-of-the-art treatment of chronic lymphocytic leukemia.
Journal: Hematology. American Society of Hematology. Education Program 20090101
Title: The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081215
Title: A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Journal: Pediatric transplantation 20081201
Title: Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Journal: Leukemia research 20081201
Title: Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia.
Journal: Hematological oncology 20081201
Title: Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia.
Journal: Oral and maxillofacial surgery 20081201
Title: Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.
Journal: Bone marrow transplantation 20081201
Title: 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation 20081201
Title: Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
Journal: Haematologica 20081201
Title: Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
Journal: British journal of haematology 20081201
Title: Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
Journal: Molecular cancer research : MCR 20081201
Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
Title: Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110
Title: Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
Journal: Mutation research 20081110
Title: Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes.
Journal: Molecular and cellular endocrinology 20081106
Title: Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
Journal: Annals of hematology 20081101
Title: Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
Journal: Leukemia 20081101
Title: Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Journal: Blood 20081101
Title: Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20081101
Title: Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
Journal: European journal of haematology 20081101
Title: p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism.
Journal: Blood 20081101
Title: Images in haematology. Cerebral nocardiosis in a patient with lymphoplasmacytic lymphoma treated with fludarabine.
Journal: British journal of haematology 20081101
Title: Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
Journal: Leukemia 20081101
Title: Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
Journal: Haematologica 20081101
Title: Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
Title: Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
Title: Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
Journal: British journal of haematology 20081101
Title: Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.
Journal: European journal of medical research 20081027
Title: Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Journal: Transplantation 20081015
Title: Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
Journal: Cancer chemotherapy and pharmacology 20081001
Title: Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone.
Journal: Leukemia & lymphoma 20081001
Title: [Chronic lymphocytic leukemia and the related disorders].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20081001
Title: Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.
Journal: Molecular cancer therapeutics 20081001
Title: Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
Journal: Bone marrow transplantation 20081001
Title: Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
Journal: Chinese medical journal 20080920
Title: Imatinib inhibition of fludarabine uptake in T-lymphocytes.
Journal: Cancer chemotherapy and pharmacology 20080901
Title: Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
Journal: Leukemia 20080901
Title: Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
Journal: Blood 20080901
Title: Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
Journal: American journal of hematology 20080901
Title: Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
Journal: Haematologica 20080901
Title: Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia.
Journal: Current oncology reports 20080901
Title: Pentostatin in chronic lymphocytic leukemia.
Journal: Expert opinion on drug metabolism & toxicology 20080901
Title: Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901
Title: Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience.
Journal: Pediatric transplantation 20080901
Title: Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.
Journal: Blood 20080815
Title: The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes.
Journal: Blood 20080815
Title: Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.
Journal: Pharmacy world & science : PWS 20080801
Title: Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
Journal: American journal of hematology 20080801
Title: Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.
Journal: Bone marrow transplantation 20080801
Title: Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
Title: Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
Title: Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
Title: [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].
Journal: Zhongguo shi yan xue ye xue za zhi 20080801
Title: Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Journal: Leukemia & lymphoma 20080801
Title: Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.
Journal: Blood 20080715
Title: Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Journal: Transplant infectious disease : an official journal of the Transplantation Society 20080701
Title: Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure.
Journal: Bone marrow transplantation 20080701
Title: Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen.
Journal: Bone marrow transplantation 20080701
Title: Selective killing of Mycobacterium avium-infected macrophages by inhibition of phosphorylated signal transducer and activator of transcription type 1.
Journal: The Journal of infectious diseases 20080701
Title: Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403.
Journal: Haematologica 20080701
Title: Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080701
Title: Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Journal: Blood 20080615
Title: [Novel medical treatment modalities in hematology].
Journal: Ugeskrift for laeger 20080609
Title: Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
Journal: Bone marrow transplantation 20080601
Title: Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
Journal: Cellular signalling 20080601
Title: Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Journal: Leukemia 20080601
Title: Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
Journal: Leukemia & lymphoma 20080601
Title: HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
Title: Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
Title: Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
Title: Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia.
Journal: British journal of haematology 20080601
Title: Non-MALT marginal zone lymphomas.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080601
Title: Fludarabine induces differential expression of proteins in human leukemia and lymphoma cells.
Journal: Nucleosides, nucleotides & nucleic acids 20080601
Title: Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells.
Journal: Journal of cellular biochemistry 20080515
Title: CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
Journal: Pediatric blood & cancer 20080501
Title: Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Journal: Annals of hematology 20080501
Title: IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro.
Journal: Blood 20080501
Title: A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Journal: Bone marrow transplantation 20080501
Title: Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
Journal: Bone marrow transplantation 20080501
Title: Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
Journal: Journal of molecular medicine (Berlin, Germany) 20080501
Title: Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Journal: British journal of haematology 20080501
Title: Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Journal: Experimental hematology 20080501
Title: Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20080501
Title: Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080501
Title: Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.
Journal: International journal of hematology 20080501
Title: Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma.
Journal: Cancer investigation 20080501
Title: Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
Journal: Saudi medical journal 20080501
Title: Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20080501
Title: Liposomal coencapsulated fludarabine and mitoxantrone for lymphoproliferative disorder treatment.
Journal: Journal of pharmaceutical sciences 20080401
Title: Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Journal: European journal of haematology 20080401
Title: High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
Journal: Bone marrow transplantation 20080401
Title: Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Journal: The Lancet. Oncology 20080401
Title: Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401
Title: Antibody therapy for chronic lymphocytic leukemia.
Journal: Seminars in hematology 20080401
Title: Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
Journal: Transfusion medicine (Oxford, England) 20080401
Title: Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Journal: Onkologie 20080401
Title: Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
Journal: Onkologie 20080401
Title: Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Journal: Cancer 20080315
Title: Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080315
Title: Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Journal: Pediatric blood & cancer 20080301
Title: Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
Journal: Leukemia 20080301
Title: Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Journal: Leukemia 20080301
Title: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Journal: Haematologica 20080301
Title: Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
Journal: British journal of haematology 20080301
Title: Phase I trial of nelarabine in indolent leukemias.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
Title: Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Journal: Haematologica 20080301
Title: High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Journal: Haematologica 20080301
Title: Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20080301
Title: [Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic stem cell transplantation].
Journal: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301
Title: The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
Journal: Blood 20080215
Title: Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Journal: Biochemical pharmacology 20080215
Title: A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
Journal: Cancer 20080215
Title: Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient.
Journal: Leukemia research 20080201
Title: Extramedullary, extranodal lymphoplasmacytic lymphoma with macroglobulinemia: long-term complete remission with fludarabine.
Journal: Annals of hematology 20080201
Title: Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Journal: International journal of radiation oncology, biology, physics 20080201
Title: Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
Journal: Bone marrow transplantation 20080201
Title: Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Journal: Leukemia 20080201
Title: Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Journal: Cell death and differentiation 20080201
Title: Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB.
Journal: Bone marrow transplantation 20080201
Title: Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal: Blood 20080201
Title: Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen.
Journal: Bone marrow transplantation 20080201
Title: Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
Journal: Blood 20080201
Title: Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
Journal: British journal of haematology 20080201
Title: Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.
Journal: Pediatric transplantation 20080201
Title: Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201
Title: Invasive fungal sinusitis in patients treated with fludarabine.
Journal: The Journal of infection 20080201
Title: Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
Title: High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
Title: Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
Title: Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Journal: Haematologica 20080201
Title: Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Journal: Haematologica 20080201
Title: High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
Journal: Haematologica 20080201
Title: Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080201
Title: BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.
Journal: Blood 20080115
Title: Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
Journal: Transplantation 20080115
Title: Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110
Title: A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders.
Journal: Leukemia research 20080101
Title: Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Journal: Blood cells, molecules & diseases 20080101
Title: Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.
Journal: Leukemia research 20080101
Title: Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080101
Title: Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
Journal: Leukemia & lymphoma 20080101
Title: Waldenström macroglobulinemia of the orbit.
Journal: Ophthalmic plastic and reconstructive surgery 20080101
Title: Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation.
Journal: International journal of hematology 20080101
Title: Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
Journal: Pediatric hematology and oncology 20080101
Title: Prodrug converting enzyme gene delivery by L. monocytogenes.
Journal: BMC cancer 20080101
Title: Paradoxical exacerbation of psoriasis during therapy with fludarabine.
Journal: European journal of dermatology : EJD 20080101
Title: Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology 20080101
Title: Severe prolonged immunosuppression following fludarabine and rituximab combination therapy.
Journal: Chemotherapy 20080101
Title: Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.
Journal: Anticancer research 20080101
Title: Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.
Journal: Immunology and cell biology 20080101
Title: Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma.
Journal: American journal of clinical dermatology 20080101
Title: Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
Journal: European journal of dermatology : EJD 20080101
Title: Fludarabine in lymphoproliferative malignancies: a single-centre experience.
Journal: The National medical journal of India 20080101
Title: Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Journal: The Egyptian journal of immunology 20080101
Title: Have we forgotten the purpose of phase III studies?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210
Title: Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.
Journal: Leukemia 20071201
Title: Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20071201
Title: Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.
Journal: Archives of biochemistry and biophysics 20071201
Title: Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201
Title: Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo.
Journal: European journal of haematology 20071201
Title: Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201
Title: Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.
Journal: Leukemia & lymphoma 20071201
Title: Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
Journal: Journal of Korean medical science 20071201
Title: Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.
Journal: International journal of hematology 20071201
Title: Graft-versus-myeloma effects in reduced-intensity cord blood transplantation.
Journal: International journal of hematology 20071201
Title: Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine.
Journal: Cancer research 20071115
Title: Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Journal: Blood 20071101
Title: Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.
Journal: Bone marrow transplantation 20071101
Title: Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
Journal: Bone marrow transplantation 20071101
Title: Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Journal: British journal of haematology 20071101
Title: Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Journal: Bone marrow transplantation 20071101
Title: Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
Journal: British journal of haematology 20071101
Title: Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101
Title: Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Journal: Experimental hematology 20071101
Title: Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
Journal: British journal of haematology 20071101
Title: [MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland].
Journal: Journal francais d'ophtalmologie 20071101
Title: Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).
Journal: International journal of hematology 20071101
Title: [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Journal: Vnitrni lekarstvi 20071101
Title: Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Journal: Blood 20071015
Title: Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
Journal: Blood 20071015
Title: Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
Journal: Leukemia 20071001
Title: Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Journal: American journal of hematology 20071001
Title: Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
Journal: American journal of hematology 20071001
Title: Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan.
Journal: Leukemia 20071001
Title: Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
Journal: Haematologica 20071001
Title: Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Journal: British journal of haematology 20071001
Title: Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
Journal: British journal of haematology 20071001
Title: A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.
Journal: British journal of haematology 20071001
Title: Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy.
Journal: Leukemia & lymphoma 20071001
Title: The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.
Journal: Leukemia & lymphoma 20071001
Title: Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia.
Journal: Leukemia & lymphoma 20071001
Title: Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
Journal: The Netherlands journal of medicine 20071001
Title: [Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia].
Journal: Zhongguo shi yan xue ye xue za zhi 20071001
Title: [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
Journal: Zhongguo shi yan xue ye xue za zhi 20071001
Title: Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia.
Journal: International journal of hematology 20071001
Title: The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
Journal: Haematologica 20071001
Title: Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia.
Journal: The Medical journal of Malaysia 20071001
Title: Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma.
Journal: Current hematologic malignancy reports 20071001
Title: Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin.
Journal: Transplantation 20070915
Title: Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
Journal: British journal of cancer 20070911
Title: Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Journal: Gene therapy 20070901
Title: Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Journal: Bone marrow transplantation 20070901
Title: New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.
Journal: Bone marrow transplantation 20070901
Title: Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070901
Title: Chemoimmunotherapy of chronic lymphocytic leukemia.
Journal: Best practice & research. Clinical haematology 20070901
Title: Minimal residual disease assessment in chronic lymphocytic leukaemia.
Journal: Best practice & research. Clinical haematology 20070901
Title: Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Journal: Pediatric hematology and oncology 20070901
Title: CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Journal: British journal of haematology 20070901
Title: Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells.
Journal: Haematologica 20070901
Title: Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
Journal: Cancer genetics and cytogenetics 20070901
Title: Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues.
Journal: Experimental oncology 20070901
Title: [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070901
Title: Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
Journal: Oncogene 20070823
Title: Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Journal: Blood 20070815
Title: Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
Journal: Annals of hematology 20070801
Title: Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
Journal: Annals of hematology 20070801
Title: Alkylator-free conditioning regimen for patients with acquired aplastic anemia, transplanted from genetically identical twins.
Journal: Pediatric transplantation 20070801
Title: Regurgitation of esophageal mucosa.
Journal: Mayo Clinic proceedings 20070801
Title: Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine.
Journal: Leukemia & lymphoma 20070801
Title: Combination therapies for previously untreated CLL.
Journal: Lancet (London, England) 20070721
Title: Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
Journal: Lancet (London, England) 20070721
Title: Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
Journal: British journal of cancer 20070716
Title: Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation.
Journal: International journal of radiation oncology, biology, physics 20070715
Title: T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Journal: Leukemia research 20070701
Title: Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation.
Journal: Bone marrow transplantation 20070701
Title: Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
Journal: Bone marrow transplantation 20070701
Title: Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation 20070701
Title: Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
Journal: Bone marrow transplantation 20070701
Title: Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
Journal: Cancer 20070701
Title: Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701
Title: Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701
Title: Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.
Journal: Experimental hematology 20070701
Title: Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
Journal: British journal of haematology 20070701
Title: Dictyostelium discoideum salvages purine deoxyribonucleosides by highly specific bacterial-like deoxyribonucleoside kinases.
Journal: Journal of molecular biology 20070608
Title: Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
Journal: American journal of hematology 20070601
Title: Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Journal: Cancer chemotherapy and pharmacology 20070601
Title: Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Journal: American journal of physiology. Heart and circulatory physiology 20070601
Title: Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Journal: Rheumatology (Oxford, England) 20070601
Title: Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Journal: International journal of oncology 20070601
Title: Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070601
Title: Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience.
Journal: Hematology (Amsterdam, Netherlands) 20070601
Title: The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
Journal: International journal of hematology 20070601
Title: Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
Journal: Leukemia & lymphoma 20070601
Title: [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20070601
Title: [Chronic lymphoid leukemia and intravenous immunoglobulins].
Journal: La Revue de medecine interne 20070601
Title: Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
Journal: Oncogene 20070528
Title: Management of symptomatic, untreated chronic lymphocytic leukemia.
Journal: Blood reviews 20070501
Title: Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay.
Journal: Cytometry. Part B, Clinical cytometry 20070501
Title: Allogeneic bone marrow transplantation for Pearson's syndrome.
Journal: Bone marrow transplantation 20070501
Title: Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
Journal: Leukemia 20070501
Title: Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501
Title: A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Journal: Journal of the American Academy of Dermatology 20070501
Title: A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070501
Title: Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
Journal: British journal of haematology 20070501
Title: In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.
Journal: International journal of hematology 20070501
Title: Acquired hemophilia in chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20070501
Title: Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Journal: Haematologica 20070501
Title: Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
Journal: Haematologica 20070501
Title: [Ulcers in a patient with chronic lymphocytic leukemia].
Journal: Actas dermo-sifiliograficas 20070501
Title: Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
Journal: Cancer chemotherapy and pharmacology 20070401
Title: Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein.
Journal: Cancer immunology, immunotherapy : CII 20070401
Title: Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Journal: Bone marrow transplantation 20070401
Title: Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Journal: Bone marrow transplantation 20070401
Title: Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401
Title: Current treatment options in prolymphocytic leukemia.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20070401
Title: Gene expression signatures that predict radiation exposure in mice and humans.
Journal: PLoS medicine 20070401
Title: Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.
Journal: Journal of Korean medical science 20070401
Title: Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Journal: Hematology (Amsterdam, Netherlands) 20070401
Title: Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma.
Journal: Leukemia & lymphoma 20070401
Title: Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation.
Journal: International journal of hematology 20070401
Title: Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
Journal: Haematologica 20070401
Title: Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320
Title: Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
Journal: Leukemia research 20070301
Title: Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Journal: Leukemia 20070301
Title: Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Journal: Leukemia 20070301
Title: Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Journal: Clinical and experimental dermatology 20070301
Title: Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
Title: Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
Journal: Transplant infectious disease : an official journal of the Transplantation Society 20070301
Title: Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
Title: Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
Title: Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation.
Journal: Haematologica 20070301
Title: Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Journal: British journal of haematology 20070301
Title: Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Journal: Leukemia & lymphoma 20070301
Title: Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Journal: Leukemia research 20070201
Title: Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia.
Journal: Leukemia research 20070201
Title: Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Journal: Clinical radiology 20070201
Title: F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan.
Journal: Bone marrow transplantation 20070201
Title: Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
Journal: Bone marrow transplantation 20070201
Title: Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Journal: Bone marrow transplantation 20070201
Title: Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation.
Journal: Onkologie 20070201
Title: Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Journal: European journal of haematology 20070201
Title: Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Journal: European journal of haematology 20070201
Title: Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
Journal: International journal of hematology 20070201
Title: 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis.
Journal: Leukemia & lymphoma 20070201
Title: Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.
Journal: Leukemia & lymphoma 20070201
Title: Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.
Journal: Haematologica 20070201
Title: Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
Journal: Journal of the National Cancer Institute 20070117
Title: Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
Journal: Leukemia research 20070101
Title: Preclinical assessment of curcumin as a potential therapy for B-CLL.
Journal: American journal of hematology 20070101
Title: Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Journal: Blood 20070101
Title: Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan.
Journal: Annals of hematology 20070101
Title: STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines.
Journal: International journal of cancer 20070101
Title: Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Journal: British journal of haematology 20070101
Title: Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Journal: Journal of the American Academy of Dermatology 20070101
Title: Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia.
Journal: Bone marrow transplantation 20070101
Title: Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
Journal: Journal of clinical pharmacology 20070101
Title: Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
Journal: British journal of haematology 20070101
Title: Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070101
Title: Improved outcome after relapse in children with acute myeloid leukaemia.
Journal: British journal of haematology 20070101
Title: Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma.
Journal: European journal of dermatology : EJD 20070101
Title: Advances in CLL.
Journal: Clinical advances in hematology & oncology : H&O 20070101
Title: Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients.
Journal: Acta haematologica 20070101
Title: Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.
Journal: Haematologica 20070101
Title: Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia.
Journal: Haematologica 20070101
Title: Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101
Title: [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?].
Journal: Revista de medicina de la Universidad de Navarra 20070101
Title: Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia.
Journal: Anticancer research 20070101
Title: Fludarabine: a review of its use in non-Hodgkin's lymphoma.
Journal: Drugs 20070101
Title: Paraneoplastic pemphigus associated with fludarabine use.
Journal: Medical oncology (Northwood, London, England) 20070101
Title: [Visual cortes--is it a concern?].
Journal: Bulletin de la Societe belge d'ophtalmologie 20070101
Title: [Allogenic transplantation of hemopoietic stem cells in low-intensity regimes in patients with hematological malignancies].
Journal: Terapevticheskii arkhiv 20070101
Title: [Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide].
Journal: Terapevticheskii arkhiv 20070101
Title: Chronic lymphocytic leukemia masquerading as uveitis.
Journal: Retina (Philadelphia, Pa.) 20070101
Title: The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines.
Journal: Nucleosides, nucleotides & nucleic acids 20070101
Title: Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin.
Journal: Asian Pacific journal of cancer prevention : APJCP 20070101
Title: Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).
Journal: Blood 20061215
Title: Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.
Journal: Blood 20061215
Title: Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Journal: Neurology 20061212
Title: Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Journal: Leukemia research 20061201
Title: Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods.
Journal: American journal of physiology. Cell physiology 20061201
Title: High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients.
Journal: American journal of hematology 20061201
Title: Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201
Title: Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201
Title: Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Journal: Leukemia & lymphoma 20061201
Title: Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Journal: Haematologica 20061201
Title: Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20061128
Title: Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
Journal: British journal of haematology 20061101
Title: Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine.
Journal: Pediatric transplantation 20061101
Title: Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
Journal: European journal of haematology 20061101
Title: Treatment-related myelodysplasia following fludarabine combination chemotherapy.
Journal: Haematologica 20061101
Title: Chronic lymphocytic leukemia: current and emerging treatment approaches.
Journal: Clinical advances in hematology & oncology : H&O 20061101
Title: Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Journal: Transplantation 20061015
Title: Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
Journal: European journal of haematology 20061001
Title: Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
Journal: British journal of haematology 20061001
Title: Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation.
Journal: Bone marrow transplantation 20061001
Title: Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.
Journal: Bone marrow transplantation 20061001
Title: Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
Journal: Cancer research 20061001
Title: Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061001
Title: Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study.
Journal: Archives of Iranian medicine 20061001
Title: Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
Title: Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
Title: Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
Title: [T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].
Journal: Zeitschrift fur Rheumatologie 20060901
Title: Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Journal: Cancer 20060901
Title: Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Journal: Bone marrow transplantation 20060901
Title: High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060901
Title: Role of fludarabine in hematological malignancies.
Journal: Expert review of anticancer therapy 20060901
Title: Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20060901
Title: Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20060901
Title: Nelarabine: a new purine analog in the treatment of hematologic malignancies.
Journal: Reviews on recent clinical trials 20060901
Title: Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Journal: Blood 20060815
Title: The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.
Journal: Cancer 20060815
Title: Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.
Journal: Blood 20060801
Title: Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis.
Journal: Bone marrow transplantation 20060801
Title: Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Journal: Journal of medical virology 20060801
Title: Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
Journal: Cancer treatment reviews 20060801
Title: Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning.
Journal: Bone marrow transplantation 20060801
Title: Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
Journal: Journal of medical microbiology 20060801
Title: A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801
Title: Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801
Title: Fludarabine in chronic lymphocytic leukaemia.
Journal: Expert opinion on pharmacotherapy 20060801
Title: Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia.
Journal: Archives of pathology & laboratory medicine 20060801
Title: MicroRNAs in leukemia.
Journal: Clinical advances in hematology & oncology : H&O 20060801
Title: Purine antagonists for chronic lymphocytic leukaemia.
Journal: The Cochrane database of systematic reviews 20060719
Title: Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.
Journal: European journal of haematology 20060701
Title: An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060701
Title: Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701
Title: Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.
Journal: Experimental hematology 20060701
Title: Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
Journal: British journal of haematology 20060701
Title: High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
Journal: British journal of haematology 20060701
Title: [Reduced-intensity cord blood transplantation for adult hematological diseases].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701
Title: [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701
Title: Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment.
Journal: Leukemia & lymphoma 20060701
Title: A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Journal: European journal of haematology 20060601
Title: Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Journal: Cancer 20060601
Title: Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Journal: American journal of hematology 20060601
Title: Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
Journal: American journal of hematology 20060601
Title: Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.
Journal: British journal of haematology 20060601
Title: Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma.
Journal: Onkologie 20060601
Title: Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Journal: International journal of hematology 20060601
Title: Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601
Title: Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
Journal: Hematology (Amsterdam, Netherlands) 20060601
Title: Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.
Journal: Hematology (Amsterdam, Netherlands) 20060601
Title: Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520
Title: Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).
Journal: Blood 20060515
Title: MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.
Journal: Blood 20060515
Title: Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Journal: Pediatric blood & cancer 20060501
Title: DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Journal: Leukemia 20060501
Title: Fludarabine induces pro-inflammatory activation of human monocytic cells through a MAPK/ERK pathway.
Journal: International immunopharmacology 20060501
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
Journal: British journal of haematology 20060501
Title: Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor.
Journal: International journal of hematology 20060501
Title: Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.
Journal: International journal of hematology 20060501
Title: The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.
Journal: The Journal of biological chemistry 20060414
Title: Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter.
Journal: Gene 20060412
Title: Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Journal: Journal of cellular physiology 20060401
Title: Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.
Journal: Leukemia research 20060401
Title: Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
Journal: Bone marrow transplantation 20060401
Title: The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia.
Journal: Haematologica 20060401
Title: Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401
Title: Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Journal: Seminars in hematology 20060401
Title: Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
Journal: American journal of hematology 20060401
Title: The infectious consequences of rituximab addition to fludarabine-containing regimens.
Journal: Blood 20060401
Title: [State of the art in the treatment of chronic leukemias].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20060401
Title: PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes.
Journal: Chemico-biological interactions 20060325
Title: Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy.
Journal: Spinal cord 20060301
Title: Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
Journal: Bone marrow transplantation 20060301
Title: Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
Journal: Cancer 20060301
Title: Positron emission tomography--positive distal femur following fludarabine, dexamethasone and mitoxantrone chemotherapy.
Journal: British journal of haematology 20060301
Title: Guidelines on the management of Waldenström macroglobulinaemia.
Journal: British journal of haematology 20060301
Title: Exacerbation of chronic epidural abscess following a fludarabine-based preparative regimen.
Journal: American journal of hematology 20060301
Title: Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
Journal: American journal of hematology 20060301
Title: Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060301
Title: [Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism].
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20060301
Title: F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.
Journal: Nucleosides, nucleotides & nucleic acids 20060301
Title: Advances in the treatment of chronic lymphocytic leukemia.
Journal: Current hematologic malignancy reports 20060301
Title: Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Journal: Blood 20060201
Title: Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060201
Title: Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
Journal: Bone marrow transplantation 20060201
Title: Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Journal: Bone marrow transplantation 20060201
Title: Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
Journal: European journal of haematology 20060201
Title: Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Journal: Bone marrow transplantation 20060201
Title: Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Journal: Clinical and laboratory haematology 20060201
Title: Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201
Title: Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.
Journal: Apoptosis : an international journal on programmed cell death 20060201
Title: [Effect of inhibitors of signal transducer and activator of transcription-1/3 on expression of tumor necrosis factor-alpha induced by high mobility group box-1 protein inflammatory response in rat peritoneal macrophages].
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery] 20060201
Title: Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120
Title: A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens.
Journal: Cancer 20060115
Title: Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.
Journal: Blood 20060101
Title: Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20060101
Title: A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
Journal: Molecular pharmacology 20060101
Title: Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Journal: Leukemia & lymphoma 20060101
Title: Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
Journal: European journal of haematology 20060101
Title: The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060101
Title: Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Journal: Japanese journal of clinical oncology 20060101
Title: Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study.
Journal: Acta haematologica 20060101
Title: Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Journal: International journal of hematology 20060101
Title: Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
Journal: JPMA. The Journal of the Pakistan Medical Association 20060101
Title: [Allogeneic stem cell transplantation with fludarabine/melphalan (non-TBI and non-BU/CY) for patients aged 50 or more].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20060101
Title: Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: [Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine].
Journal: Enfermedades infecciosas y microbiologia clinica 20060101
Title: Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine.
Journal: Nucleosides, nucleotides & nucleic acids 20060101
Title: [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Journal: Terapevticheskii arkhiv 20060101
Title: IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Journal: American journal of therapeutics 20060101
Title: High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.
Journal: Medical oncology (Northwood, London, England) 20060101
Title: Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues.
Journal: Nucleosides, nucleotides & nucleic acids 20060101
Title: Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220
Title: The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Journal: Cancer 20051215
Title: OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.
Journal: Journal of the National Cancer Institute 20051207
Title: Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
Journal: Bone marrow transplantation 20051201
Title: Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.
Journal: Bone marrow transplantation 20051201
Title: Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
Journal: Leukemia & lymphoma 20051201
Title: Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Journal: European journal of haematology 20051201
Title: Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Journal: Clinical transplantation 20051201
Title: Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20051201
Title: Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Journal: Haematologica 20051201
Title: [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Journal: Ai zheng = Aizheng = Chinese journal of cancer 20051201
Title: Significance of VH genes mutation status for prognosis of CLL patients.
Journal: Experimental oncology 20051201
Title: Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).
Journal: Blood 20051115
Title: An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning.
Journal: Transplantation 20051115
Title: Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Journal: Blood 20051101
Title: FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
Journal: Annals of hematology 20051101
Title: Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
Journal: Leukemia 20051101
Title: Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20051101
Title: Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma.
Journal: Clinical lymphoma & myeloma 20051101
Title: [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
Journal: Fukuoka igaku zasshi = Hukuoka acta medica 20051101
Title: Richter's syndrome--the downside of fludarabine?
Journal: Leukemia research 20051001
Title: Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Journal: Leukemia research 20051001
Title: Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
Journal: Leukemia 20051001
Title: Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Journal: International journal of oncology 20051001
Title: Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001
Title: Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
Journal: Japanese journal of clinical oncology 20051001
Title: Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
Journal: British journal of haematology 20051001
Title: High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.
Journal: Therapeutic drug monitoring 20051001
Title: Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051001
Title: Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
Journal: British journal of haematology 20051001
Title: Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20051001
Title: [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine].
Journal: Deutsche medizinische Wochenschrift (1946) 20050923
Title: Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.
Journal: Blood 20050915
Title: Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Journal: Blood 20050901
Title: Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation.
Journal: Leukemia & lymphoma 20050901
Title: 'Specific' cutaneous infiltrate of B-cell chronic lymphocytic leukemia at the site of a florid herpes simplex infection.
Journal: Journal of cutaneous pathology 20050901
Title: Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.
Journal: British journal of haematology 20050901
Title: Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.
Journal: Clinical lymphoma & myeloma 20050901
Title: [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
Journal: Orvosi hetilap 20050821
Title: Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
Title: Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
Title: Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
Title: Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
Title: [Treatment of refractory and relapsed acute lymphocytic leukemia in adults].
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050818
Title: Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
Journal: Bone marrow transplantation 20050801
Title: Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
Journal: American journal of hematology 20050801
Title: 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
Journal: British journal of haematology 20050801
Title: The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
Journal: Blood 20050715
Title: Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Journal: Cancer 20050715
Title: Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Journal: Annals of hematology 20050701
Title: An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
Journal: Japanese journal of clinical oncology 20050701
Title: Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: case report and review of literature.
Journal: American journal of hematology 20050701
Title: Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701
Title: Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20050701
Title: Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20050701
Title: Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
Journal: British journal of haematology 20050701
Title: A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050625
Title: Changing the way we think about chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
Title: Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
Title: Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
Title: Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
Journal: Blood 20050615
Title: Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
Journal: Biochemical and biophysical research communications 20050603
Title: Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
Journal: Blood 20050601
Title: Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Journal: Leukemia 20050601
Title: Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601
Title: CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors.
Journal: Bone marrow transplantation 20050601
Title: Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure.
Journal: European journal of haematology 20050601
Title: Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Journal: Cancer treatment reviews 20050601
Title: Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
Journal: British journal of haematology 20050601
Title: Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050601
Title: Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601
Title: An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
Journal: Clinical and laboratory haematology 20050601
Title: Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature.
Journal: Annals of diagnostic pathology 20050601
Title: Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.
Journal: Haematologica 20050601
Title: Economic assessment on the management of chronic lymphocytic leukaemia.
Journal: Expert opinion on pharmacotherapy 20050601
Title: The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
Journal: Clinical lymphoma 20050601
Title: FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.
Journal: JPMA. The Journal of the Pakistan Medical Association 20050601
Title: Apoptosis of peripheral human blood lymphocytes induced by physical-chemical influences and generation of reactive oxygen species.
Journal: Annals of the New York Academy of Sciences 20050601
Title: Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.
Journal: International journal of hematology 20050601
Title: Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
Journal: European journal of pharmacology 20050509
Title: Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
Journal: Annals of hematology 20050501
Title: Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
Journal: Bone marrow transplantation 20050501
Title: Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity.
Journal: Bone marrow transplantation 20050501
Title: Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Journal: Haematologica 20050501
Title: Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Journal: Haematologica 20050501
Title: Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.
Journal: The Journal of biological chemistry 20050422
Title: Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine.
Journal: Annals of hematology 20050401
Title: Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
Journal: Leukemia research 20050401
Title: Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Journal: Bone marrow transplantation 20050401
Title: Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
Journal: European journal of haematology 20050401
Title: Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF.
Journal: Bone marrow transplantation 20050401
Title: Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401
Title: p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
Journal: British journal of haematology 20050401
Title: Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Journal: British journal of haematology 20050401
Title: Five-month marrow aplasia in a child with refractory acute myeloid leukemia: successful management with continuous granulocyte support and reduced-intensity conditioning followed by matched unrelated bone marrow transplantation.
Journal: Journal of pediatric hematology/oncology 20050401
Title: Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.
Journal: Stem cells and development 20050401
Title: Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.
Journal: Leukemia & lymphoma 20050401
Title: Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050320
Title: Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose.
Journal: Blood 20050315
Title: Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
Journal: The Journal of biological chemistry 20050311
Title: Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
Journal: Blood 20050301
Title: Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20050301
Title: Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
Journal: Bone marrow transplantation 20050301
Title: Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
Journal: Bone marrow transplantation 20050301
Title: Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis.
Journal: British journal of haematology 20050301
Title: Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20050301
Title: Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation 20050301
Title: [Current and new therapeutic strategies in acute myeloid leukemia].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20050301
Title: Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Journal: Clinical lymphoma 20050301
Title: [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].
Journal: Bulletin du cancer 20050301
Title: [News in therapeutic management of chronic lymphoid leukemia].
Journal: Bulletin du cancer 20050301
Title: High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
Journal: International journal of cancer 20050220
Title: Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
Journal: Bone marrow transplantation 20050201
Title: Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor.
Journal: Pediatric transplantation 20050201
Title: Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201
Title: The role of mitoxantrone in the treatment of indolent lymphomas.
Journal: The oncologist 20050201
Title: Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
Journal: Haematologica 20050201
Title: Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
Journal: Haematologica 20050201
Title: Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia.
Journal: Stem cells and development 20050201
Title: Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201
Title: Lymphoma: diagnosis, staging, natural history, and treatment strategies.
Journal: Seminars in oncology 20050201
Title: Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Journal: Blood 20050115
Title: Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
Journal: Blood 20050101
Title: Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
Journal: Leukemia 20050101
Title: Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
Journal: Bone marrow transplantation 20050101
Title: Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine.
Journal: Haematologica 20050101
Title: PNP with Waldenström's macroglobulinaemia.
Journal: Clinical and experimental dermatology 20050101
Title: Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia.
Journal: International journal of hematology 20050101
Title: Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).
Journal: The pharmacogenomics journal 20050101
Title: In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
Journal: Neoplasma 20050101
Title: Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication.
Journal: Cell biology international 20050101
Title: Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
Journal: Anticancer research 20050101
Title: Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
Journal: Neoplasma 20050101
Title: Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20050101
Title: Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Journal: Annals of the New York Academy of Sciences 20050101
Title: Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
Journal: Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101
Title: [Progress and perspectives in the treatment of systemic lupus erythematosus].
Journal: Przeglad lekarski 20050101
Title: [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20050101
Title: Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway.
Journal: Oncogene 20041216
Title: Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Journal: Blood 20041201
Title: Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine.
Journal: Leukemia 20041201
Title: Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
Journal: Bone marrow transplantation 20041201
Title: Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Journal: Bone marrow transplantation 20041201
Title: Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.
Journal: Bone marrow transplantation 20041201
Title: VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
Journal: European journal of haematology 20041201
Title: The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
Journal: European journal of haematology 20041201
Title: The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
Journal: International journal of oncology 20041201
Title: Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20041201
Title: Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Journal: Haematologica 20041201
Title: Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
Journal: Haematologica 20041201
Title: A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.
Journal: Haematologica 20041201
Title: Effect of fludarabine on leukocyte functions.
Journal: Chemotherapy 20041201
Title: Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion.
Journal: Cell cycle (Georgetown, Tex.) 20041201
Title: Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma 20041201
Title: Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Journal: Saudi medical journal 20041201
Title: Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
Journal: Oncogene 20041125
Title: The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Journal: Blood 20041115
Title: Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Journal: Annals of hematology 20041101
Title: A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.
Journal: Cancer 20041101
Title: Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Journal: Leukemia 20041101
Title: Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes.
Journal: Biochemical pharmacology 20041101
Title: Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion.
Journal: British journal of haematology 20041101
Title: Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041101
Title: Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis.
Journal: Leukemia & lymphoma 20041101
Title: Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
Journal: Leukemia & lymphoma 20041101
Title: Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance.
Journal: Internal medicine (Tokyo, Japan) 20041101
Title: The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
Journal: Folia morphologica 20041101
Title: Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.
Journal: Blood 20041015
Title: Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal: Blood 20041015
Title: A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20041015
Title: Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
Journal: European journal of haematology 20041001
Title: Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20041001
Title: Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
Journal: Leukemia & lymphoma 20041001
Title: Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041001
Title: Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001
Title: [Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study].
Journal: Zhongguo shi yan xue ye xue za zhi 20041001
Title: Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.
Journal: Nucleosides, nucleotides & nucleic acids 20041001
Title: Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Journal: Blood 20040915
Title: The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
Journal: Cancer research 20040915
Title: Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.
Journal: Blood 20040901
Title: Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20040901
Title: Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).
Journal: Leukemia & lymphoma 20040901
Title: BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Journal: Leukemia 20040901
Title: The role of fludarabine in the treatment of follicular and mantle cell lymphoma.
Journal: Cancer 20040901
Title: [New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia].
Journal: Orvosi hetilap 20040829
Title: Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia.
Journal: Neurology 20040810
Title: Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Journal: Blood 20040801
Title: Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors.
Journal: Bone marrow transplantation 20040801
Title: Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
Journal: European journal of haematology 20040801
Title: Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue.
Journal: Cancer biology & therapy 20040801
Title: Fatal peripheral neuropathy following FLA chemotherapy.
Journal: Clinical and laboratory haematology 20040801
Title: Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
Journal: British journal of haematology 20040801
Title: Cytopenia and hematopoietic recovery after low intensity conditioning transplants.
Journal: Croatian medical journal 20040801
Title: Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.
Journal: Arthritis and rheumatism 20040801
Title: The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
Journal: Leukemia 20040701
Title: Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.
Journal: Bone marrow transplantation 20040701
Title: Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
Journal: Leukemia research 20040701
Title: Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Journal: Journal of the American Society of Nephrology : JASN 20040701
Title: 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.
Journal: Molecular pharmacology 20040701
Title: Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation.
Journal: Bone marrow transplantation 20040701
Title: Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients.
Journal: Bone marrow transplantation 20040701
Title: Guillain-Barré syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20040701
Title: Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Journal: Clinical advances in hematology & oncology : H&O 20040701
Title: Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
Journal: Cancer 20040615
Title: Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Journal: Bone marrow transplantation 20040601
Title: Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
Journal: Blood 20040601
Title: Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040601
Title: Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Journal: Haematologica 20040601
Title: Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Journal: Leukemia & lymphoma 20040601
Title: Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study.
Journal: Leukemia & lymphoma 20040601
Title: High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
Journal: The Korean journal of internal medicine 20040601
Title: Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction.
Journal: The Biochemical journal 20040515
Title: Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
Journal: Cancer 20040515
Title: Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Journal: Cancer 20040515
Title: Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.
Journal: Blood 20040501
Title: Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.
Journal: Leukemia 20040501
Title: Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
Journal: Bone marrow transplantation 20040501
Title: High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma.
Journal: Bone marrow transplantation 20040501
Title: Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Journal: Leukemia research 20040501
Title: Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium.
Journal: Leukemia research 20040501
Title: Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20040501
Title: Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
Journal: The American journal of surgical pathology 20040501
Title: Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20040501
Title: The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.
Journal: Blood 20040415
Title: Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.
Journal: Annals of hematology 20040401
Title: Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Journal: Bone marrow transplantation 20040401
Title: Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Journal: Molecular pharmacology 20040401
Title: The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
Journal: Cancer research 20040401
Title: Aspergillus fumigatus: a rare cause of vertebral osteomyelitis.
Journal: Haematologica 20040401
Title: [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].
Journal: Ai zheng = Aizheng = Chinese journal of cancer 20040401
Title: Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy.
Journal: Clinical nuclear medicine 20040401
Title: Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins.
Journal: Croatian medical journal 20040401
Title: A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.
Journal: Leukemia research 20040401
Title: Treatment of chronic lymphocytic leukemia.
Journal: Seminars in oncology 20040401
Title: Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia.
Journal: International journal of hematology 20040401
Title: [Waldenstrom macroglobulinemia].
Journal: Praxis 20040331
Title: Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Journal: Blood 20040301
Title: Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Journal: Bone marrow transplantation 20040301
Title: Reversible acute renal failure following single administration of fludarabine.
Journal: Bone marrow transplantation 20040301
Title: [Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040301
Title: Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.
Journal: Leukemia research 20040201
Title: Nonmyeloablative stem cell transplantation for lymphoma.
Journal: Seminars in oncology 20040201
Title: [Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20040201
Title: Advancing therapy for chronic lymphocytic leukemia--the role of rituximab.
Journal: Seminars in oncology 20040201
Title: High dose chlorambucil in the treatment of lymphoid malignancies.
Journal: Leukemia & lymphoma 20040201
Title: Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Journal: Blood 20040115
Title: Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation.
Journal: Blood 20040115
Title: Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040105
Title: Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.
Journal: Blood 20040101
Title: Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
Journal: Leukemia 20040101
Title: Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.
Journal: Leukemia 20040101
Title: Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
Journal: British journal of haematology 20040101
Title: Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.
Journal: British journal of haematology 20040101
Title: Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Journal: Current hematology reports 20040101
Title: Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.
Journal: Gynecologic oncology 20040101
Title: Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040101
Title: Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Journal: International journal of hematology 20040101
Title: Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
Journal: Leukemia & lymphoma 20040101
Title: Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Use of fludarabine in the treatment of acute myeloid leukemia.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Future prospects for fludarabine-containing regimens in the treatment of hematological cancers.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
Journal: Annals of hematology 20040101
Title: Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Journal: The Annals of pharmacotherapy 20040101
Title: Fludarabine combination regimen severely affected peripheral blood stem cell mobilization.
Journal: Acta haematologica 20040101
Title: Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.
Journal: BMC pharmacology 20040101
Title: A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Fludarabine as the possible cause of acute myelofibrosis.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Reconstructing immunity after allogeneic transplantation.
Journal: Immunologic research 20040101
Title: Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20040101
Title: Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Purine analogs in leukemia.
Journal: Advances in pharmacology (San Diego, Calif.) 20040101
Title: Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: Effects of fludarabine treatment on murine lupus nephritis.
Journal: Lupus 20040101
Title: [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
Journal: Voprosy onkologii 20040101
Title: Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.
Journal: Cancer chemotherapy and pharmacology 20031201
Title: In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine.
Journal: Biochemical pharmacology 20031201
Title: Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies.
Journal: Clinical and laboratory haematology 20031201
Title: Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
Journal: Transfusion 20031201
Title: Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Journal: International journal of clinical oncology 20031201
Title: Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Journal: Haematologica 20031201
Title: [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Journal: Ai zheng = Aizheng = Chinese journal of cancer 20031201
Title: B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen.
Journal: Transplantation proceedings 20031201
Title: [Hairy cell leukemia: report on one case with survival for 10 years].
Journal: Zhongguo shi yan xue ye xue za zhi 20031201
Title: 45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
Journal: Clinical lymphoma 20031201
Title: Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
Journal: Leukemia & lymphoma 20031201
Title: [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
Journal: Nederlands tijdschrift voor geneeskunde 20031122
Title: Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine.
Journal: Biochemical and biophysical research communications 20031121
Title: Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Journal: Blood 20031115
Title: Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
Journal: Oncogene 20031113
Title: Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
Journal: Journal of leukocyte biology 20031101
Title: The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
Journal: Bone marrow transplantation 20031101
Title: Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.
Journal: Annals of the rheumatic diseases 20031101
Title: Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Journal: Haematologica 20031101
Title: Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
Journal: British journal of haematology 20031101
Title: Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20031101
Title: Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Journal: Leukemia research 20031001
Title: Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
Journal: Bone marrow transplantation 20031001
Title: The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
Journal: British journal of haematology 20031001
Title: Fludarabine-related myeloid leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001
Title: Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin.
Journal: Leukemia 20031001
Title: Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Journal: Journal of pediatric hematology/oncology 20031001
Title: Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
Journal: Experimental hematology 20031001
Title: Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20031001
Title: [Modified FLAG regimen in the management of refractory acute myeloid leukemia].
Journal: Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001
Title: Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001
Title: Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy.
Journal: Leukemia & lymphoma 20031001
Title: Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20031001
Title: Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
Journal: JPMA. The Journal of the Pakistan Medical Association 20031001
Title: [Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia].
Journal: MMW Fortschritte der Medizin 20030925
Title: HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Journal: Blood 20030915
Title: Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia.
Journal: Blood 20030915
Title: Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
Journal: Blood 20030901
Title: Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia.
Journal: Cancer chemotherapy and pharmacology 20030901
Title: Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.
Journal: Annals of hematology 20030901
Title: Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
Journal: Bone marrow transplantation 20030901
Title: A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Journal: Bone marrow transplantation 20030901
Title: A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030901
Title: [Non-myeloablative or reduced intensity stem cell transplantation preparative regimens].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Mini-transplantation from HLA-mismatched donors].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Mini-transplantation from cord blood].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Reduced-intensity stem cell transplantation (RIST) for lymphoproliferative diseases].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Non-myeloablative stem cell transplantation for non-malignant hematologic disorders].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Gastrointestinal cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: [Nonmyeloablative allogeneic peripheral blood stem cell transplantation of renal cell carcinoma].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030901
Title: The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
Journal: Leukemia & lymphoma 20030901
Title: Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.
Journal: Blood 20030801
Title: Bilateral optic disc swelling as the presenting sign of Waldenström's macroglobulinaemia.
Journal: Acta ophthalmologica Scandinavica 20030801
Title: Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria.
Journal: European journal of haematology 20030801
Title: A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement.
Journal: Clinical and laboratory haematology 20030801
Title: Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
Journal: Bone marrow transplantation 20030801
Title: Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030801
Title: Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030801
Title: Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Journal: Haematologica 20030801
Title: Early reappearance of primary solid cancer in patients treated with purine analogs.
Journal: Journal of chemotherapy (Florence, Italy) 20030801
Title: [Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801
Title: [Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801
Title: Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Journal: Blood 20030715
Title: Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Journal: Blood 20030715
Title: Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715
Title: [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
Journal: MMW Fortschritte der Medizin 20030710
Title: Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
Journal: European journal of haematology 20030701
Title: Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
Journal: Bone marrow transplantation 20030701
Title: Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701
Title: Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701
Title: Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701
Title: Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20030701
Title: Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells.
Journal: Bulletin of experimental biology and medicine 20030701
Title: Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
Journal: The Journal of the Association of Physicians of India 20030701
Title: [Evidence-based therapy for chronic leukemia].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20030610
Title: Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Journal: Annals of hematology 20030601
Title: Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.
Journal: Hematology (Amsterdam, Netherlands) 20030601
Title: Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study.
Journal: European journal of haematology 20030601
Title: Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Journal: Leukemia 20030601
Title: Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
Journal: Bone marrow transplantation 20030601
Title: Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Journal: British journal of haematology 20030601
Title: Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand.
Journal: British journal of haematology 20030601
Title: Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Journal: Leukemia & lymphoma 20030601
Title: Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515
Title: Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Journal: Leukemia research 20030501
Title: Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Journal: The Annals of pharmacotherapy 20030501
Title: Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Journal: Bone marrow transplantation 20030501
Title: Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
Journal: Bone marrow transplantation 20030501
Title: Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Journal: Leukemia 20030501
Title: Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.
Journal: Leukemia 20030501
Title: Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415
Title: Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Journal: Cancer 20030401
Title: Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401
Title: Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Journal: American journal of hematology 20030401
Title: Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Journal: Haematologica 20030401
Title: Bilateral orbital masses in a patient with B-cell chronic lymph.
Journal: Haematologica 20030401
Title: Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies.
Journal: British journal of haematology 20030401
Title: Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine.
Journal: Annals of hematology 20030401
Title: Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.
Journal: Cell death and differentiation 20030401
Title: Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
Journal: Seminars in oncology 20030401
Title: Fludarabine in Waldenstrom's macroglobulinemia.
Journal: Seminars in oncology 20030401
Title: Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030401
Title: Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment.
Journal: Leukemia & lymphoma 20030401
Title: Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
Journal: Leukemia & lymphoma 20030401
Title: Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
Journal: Blood 20030315
Title: Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.
Journal: Statistics in medicine 20030315
Title: Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Journal: Cancer 20030315
Title: Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines.
Journal: Bioorganic & medicinal chemistry letters 20030310
Title: Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty.
Journal: Blood 20030301
Title: Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Journal: American journal of hematology 20030301
Title: Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).
Journal: Haematologica 20030301
Title: Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301
Title: Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
Journal: Bone marrow transplantation 20030301
Title: Purine nucleoside analogues in the treatment of myleoid leukemias.
Journal: Leukemia & lymphoma 20030301
Title: Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20030301
Title: Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.
Journal: Leukemia & lymphoma 20030301
Title: Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature.
Journal: Leukemia & lymphoma 20030301
Title: Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Journal: Blood 20030215
Title: Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Journal: American journal of hematology 20030201
Title: Advances in the treatment of hairy-cell leukaemia.
Journal: The Lancet. Oncology 20030201
Title: Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030201
Title: Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity.
Journal: British journal of haematology 20030201
Title: The relevance of nonmyeloablative transplants in developing countries: lessons from the UK experience.
Journal: Transplantation proceedings 20030201
Title: A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
Journal: Leukemia 20030201
Title: CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
Journal: Haematologica 20030201
Title: Immune thrombocytopenia induced by fludarabine successfully treated with rituximab.
Journal: Haematologica 20030201
Title: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Journal: Bone marrow transplantation 20030201
Title: Rituximab plus chemotherapy in follicular and mantle cell lymphomas.
Journal: Seminars in oncology 20030201
Title: Rituximab in chronic lymphocytic leukemia.
Journal: Seminars in oncology 20030201
Title: Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine.
Journal: Leukemia & lymphoma 20030201
Title: Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.
Journal: Blood 20030115
Title: The effects of cladribine and fludarabine on DNA methylation in K562 cells.
Journal: Biochemical pharmacology 20030115
Title: Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Journal: Biochemical pharmacology 20030115
Title: Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Journal: Blood 20030101
Title: Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
Journal: Cancer gene therapy 20030101
Title: Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
Journal: British journal of haematology 20030101
Title: Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia.
Journal: Bone marrow transplantation 20030101
Title: Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Journal: Acta haematologica 20030101
Title: Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101
Title: Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
Journal: Medical oncology (Northwood, London, England) 20030101
Title: The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Journal: Archivum immunologiae et therapiae experimentalis 20030101
Title: [Long-term results of treatment of chronic B-cell lymphoid leukocytes in persons who participated in the elimination of the effects of the nuclear accident at the Chernobyl nuclear station].
Journal: Likars'ka sprava 20030101
Title: Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.
Journal: Urologic oncology 20030101
Title: Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab.
Journal: The hematology journal : the official journal of the European Haematology Association 20030101
Title: Oral fludarabine.
Journal: Drugs 20030101
Title: Oral fludarabine: a viewpoint by Dieter Huhn.
Journal: Drugs 20030101
Title: Oral fludarabine: a viewpoint by David Oscier.
Journal: Drugs 20030101
Title: Oral fludarabine: a viewpoint by Bruce D. Cheson.
Journal: Drugs 20030101
Title: [Cytogenetic changes in the Namalwa cell line of human malignant lymphoma induced by inhibitors of DNA replication and synthesis].
Journal: TSitologiia i genetika 20030101
Title: Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia.
Journal: Neoplasma 20030101
Title: Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Journal: Blood 20021215
Title: Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Journal: Blood 20021215
Title: Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.
Journal: Blood 20021215
Title: Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215
Title: Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Journal: Blood 20021201
Title: Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
Journal: British journal of haematology 20021201
Title: Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia.
Journal: British journal of haematology 20021201
Title: Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Journal: Bone marrow transplantation 20021201
Title: Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
Journal: Bone marrow transplantation 20021201
Title: Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Journal: Bone marrow transplantation 20021201
Title: Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Journal: Clinical lymphoma 20021201
Title: Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Journal: Haematologica 20021201
Title: Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.
Journal: Journal of experimental & clinical cancer research : CR 20021201
Title: The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
Journal: Blood 20021101
Title: Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Journal: Blood 20021101
Title: Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Journal: Blood 20021101
Title: Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.
Journal: British journal of haematology 20021101
Title: Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine.
Journal: Haematologica 20021101
Title: Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience.
Journal: Bone marrow transplantation 20021101
Title: [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].
Journal: Revue neurologique 20021101
Title: [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20021101
Title: [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
Journal: Deutsche medizinische Wochenschrift (1946) 20021025
Title: Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels.
Journal: Virology 20021025
Title: The triterpenoid CDDO induces apoptosis in refractory CLL B cells.
Journal: Blood 20021015
Title: CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
Journal: American journal of hematology 20021001
Title: Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.
Journal: Clinical and laboratory haematology 20021001
Title: Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome.
Journal: British journal of haematology 20021001
Title: The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas.
Journal: Anti-cancer drugs 20021001
Title: Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.
Journal: Blood 20020915
Title: Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Journal: Blood 20020915
Title: Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915
Title: Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915
Title: Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia.
Journal: Blood 20020901
Title: Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Journal: Molecular pharmacology 20020901
Title: Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study.
Journal: Leukemia 20020901
Title: Fludarabine treatment of cryoglobulinemic glomerulonephritis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901
Title: Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.
Journal: Haematologica 20020901
Title: Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis.
Journal: American journal of hematology 20020901
Title: Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes.
Journal: Chest 20020901
Title: Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin.
Journal: Bone marrow transplantation 20020901
Title: Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
Journal: Bone marrow transplantation 20020901
Title: Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
Journal: Annals of hematology 20020901
Title: Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
Journal: The Israel Medical Association journal : IMAJ 20020901
Title: [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
Journal: Polskie Archiwum Medycyny Wewnetrznej 20020901
Title: Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma 20020901
Title: Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Journal: Leukemia & lymphoma 20020901
Title: Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
Journal: Seminars in oncology 20020801
Title: Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.
Journal: Journal of hematotherapy & stem cell research 20020801
Title: Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas.
Journal: Bone marrow transplantation 20020801
Title: Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
Journal: European journal of haematology 20020801
Title: Waldenström's macroglobulinemia: a review of therapy.
Journal: Leukemia & lymphoma 20020801
Title: Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome.
Journal: Leukemia & lymphoma 20020801
Title: Haploidentical stem cell transplantation for acute leukemia.
Journal: International journal of hematology 20020801
Title: Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Journal: International journal of hematology 20020801
Title: [Clinical pharmacology of nucleoside analogues].
Journal: Bulletin du cancer 20020801
Title: Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
Journal: Oncogene 20020704
Title: Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.
Journal: Blood 20020701
Title: Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.
Journal: Haematologica 20020701
Title: Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine.
Journal: Haematologica 20020701
Title: Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning.
Journal: British journal of haematology 20020701
Title: Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Journal: Cancer chemotherapy and pharmacology 20020701
Title: Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Journal: American journal of hematology 20020701
Title: Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature.
Journal: American journal of hematology 20020701
Title: Cast nephropathy in a case of Waldenström's macroglobulinemia.
Journal: Nephron 20020701
Title: Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
Journal: European journal of haematology 20020701
Title: [Experience with fludarabine treatment and review of the literature].
Journal: Orvosi hetilap 20020616
Title: Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Journal: Haematologica 20020601
Title: Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Journal: Leukemia 20020601
Title: Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
Journal: Leukemia 20020601
Title: Challenges in treating hematologic malignancies.
Journal: Seminars in oncology 20020601
Title: Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Journal: Clinical lymphoma 20020601
Title: Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Journal: Clinical lymphoma 20020601
Title: Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Journal: Blood 20020515
Title: CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia.
Journal: Leukemia research 20020501
Title: Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.
Journal: The American journal of surgical pathology 20020501
Title: Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
Journal: American journal of hematology 20020501
Title: Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
Journal: American journal of hematology 20020501
Title: Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Journal: Cancer 20020501
Title: Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
Journal: Annals of hematology 20020501
Title: Fludarabine-induced eosinophilia: case report.
Journal: Annals of hematology 20020501
Title: Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.
Journal: Japanese journal of cancer research : Gann 20020501
Title: A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020501
Title: Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy.
Journal: The Netherlands journal of medicine 20020501
Title: Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Journal: Cancer 20020401
Title: Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Journal: Leukemia 20020401
Title: Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
Journal: Bone marrow transplantation 20020401
Title: Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
Journal: Pathology 20020401
Title: Immunochemotherapy in indolent non-Hodgkin's lymphoma.
Journal: Seminars in oncology 20020401
Title: [Fludarabine as primary therapeutic drug in chronic lymphatic leukemia].
Journal: Der Internist 20020401
Title: [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401
Title: Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.
Journal: Leukemia & lymphoma 20020401
Title: Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia.
Journal: Blood 20020315
Title: Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
Journal: Blood 20020315
Title: Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
Journal: Journal of leukocyte biology 20020301
Title: High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma.
Journal: British journal of haematology 20020301
Title: Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Journal: Clinical lymphoma 20020301
Title: Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes.
Journal: Toxicology 20020227
Title: Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Journal: Blood 20020201
Title: Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Journal: Haematologica 20020201
Title: Hematopoietic cell transplantation beyond first remission.
Journal: Leukemia 20020201
Title: Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome.
Journal: British journal of haematology 20020201
Title: Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
Journal: Seminars in oncology 20020201
Title: Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Journal: Seminars in oncology 20020201
Title: Emerging information on the use of rituximab in chronic lymphocytic leukemia.
Journal: Seminars in oncology 20020201
Title: Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.
Journal: Cancer 20020201
Title: Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.
Journal: Leukemia & lymphoma 20020201
Title: Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine.
Journal: Leukemia & lymphoma 20020201
Title: Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?
Journal: European journal of haematology 20020201
Title: Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma.
Journal: European journal of haematology 20020201
Title: Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Journal: Blood 20020115
Title: Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Journal: Blood 20020101
Title: Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease.
Journal: Experimental hematology 20020101
Title: Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
Journal: International journal of hematology 20020101
Title: Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20020101
Title: Cellular and clinical pharmacology of fludarabine.
Journal: Clinical pharmacokinetics 20020101
Title: Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
Journal: Cancer treatment and research 20020101
Title: Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation.
Journal: Cancer treatment and research 20020101
Title: Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
Journal: Leukemia & lymphoma 20020101
Title: Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.
Journal: European journal of haematology 20020101
Title: Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
Journal: Health technology assessment (Winchester, England) 20020101
Title: [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: 'minitransplant'].
Journal: Gaceta medica de Mexico 20020101
Title: Current and developing chemotherapy for CLL.
Journal: Medical oncology (Northwood, London, England) 20020101
Title: Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.
Journal: Cytotherapy 20020101
Title: Waldenström's macroglobulinemia.
Journal: Clinical journal of oncology nursing 20020101
Title: Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101
Title: The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
Journal: Cancer treatment and research 20020101
Title: Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Journal: Medical oncology (Northwood, London, England) 20020101
Title: High molecular weight DNA fragmentation assay: a sensitive method for monitoring in vivo response to antileukemic chemotherapy.
Journal: Anticancer research 20020101
Title: Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Journal: Annals of hematology 20020101
Title: Facial paresis after fludarabine treatment for advanced chronic lymphocytic leukaemia.
Journal: Haematologia 20020101
Title: Analysis of recurrent failure times data: should the baseline hazard be stratified?
Journal: Statistics in medicine 20011230
Title: Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.
Journal: Blood 20011215
Title: Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Journal: Blood 20011215
Title: Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Journal: Blood 20011215
Title: Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
Journal: Blood 20011201
Title: Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
Journal: British journal of haematology 20011201
Title: Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
Journal: Leukemia 20011201
Title: Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
Journal: British journal of haematology 20011201
Title: Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Journal: Blood 20011101
Title: Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Journal: Blood 20011101
Title: Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease.
Journal: Haematologica 20011101
Title: Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Journal: Haematologica 20011101
Title: DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011101
Title: [Chronic lymphocytic leukemias].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
Journal: Cancer 20011015
Title: Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Journal: Cancer 20011015
Title: Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis.
Journal: Leukemia 20011001
Title: Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan.
Journal: Haematologica 20011001
Title: Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
Journal: The Journal of rheumatology. Supplement 20011001
Title: Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine.
Journal: Thrombosis and haemostasis 20011001
Title: A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Journal: Bone marrow transplantation 20011001
Title: Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Journal: Bone marrow transplantation 20011001
Title: Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.
Journal: British journal of haematology 20011001
Title: Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20011001
Title: The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning.
Journal: Bone marrow transplantation 20011001
Title: Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
Journal: Bone marrow transplantation 20011001
Title: Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis.
Journal: Leukemia 20010901
Title: Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation.
Journal: Haematologica 20010901
Title: Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
Journal: Journal of neuropathology and experimental neurology 20010901
Title: Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.
Journal: British journal of haematology 20010901
Title: Therapeutic options for acute myelogenous leukemia.
Journal: Cancer 20010901
Title: Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Journal: Bone marrow transplantation 20010901
Title: Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant.
Journal: Annals of hematology 20010901
Title: Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report.
Journal: Annals of hematology 20010901
Title: Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010815
Title: Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010801
Title: Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.
Journal: British journal of haematology 20010801
Title: Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
Journal: Bone marrow transplantation 20010801
Title: Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia.
Journal: Onkologie 20010801
Title: [Drug-induced hemolytic anemia].
Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010801
Title: Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
Journal: Transplantation 20010727
Title: Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
Journal: Biochemical pharmacology 20010701
Title: Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
Journal: Blood 20010701
Title: Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
Journal: Journal of clinical epidemiology 20010701
Title: Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
Journal: British journal of haematology 20010701
Title: Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning.
Journal: Bone marrow transplantation 20010701
Title: Acute left ventricular failure following melphalan and fludarabine conditioning.
Journal: Bone marrow transplantation 20010701
Title: Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning.
Journal: Bone marrow transplantation 20010701
Title: Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation.
Journal: Bone marrow transplantation 20010701
Title: Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation.
Journal: International journal of hematology 20010701
Title: Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Journal: Leukemia & lymphoma 20010701
Title: [Chronic lymphocytic leukemia. 2. Therapy].
Journal: Deutsche medizinische Wochenschrift (1946) 20010608
Title: [Chronic lymphatic leukemia. 3. The concrete case].
Journal: Deutsche medizinische Wochenschrift (1946) 20010608
Title: UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
Journal: Experimental hematology 20010601
Title: Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Journal: Leukemia 20010601
Title: Paraneoplastic pemphigus: an association with fludarabine?
Journal: The British journal of dermatology 20010601
Title: Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Journal: Annals of the New York Academy of Sciences 20010601
Title: Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias.
Journal: Annals of hematology 20010601
Title: Non-myeloablative hematopoietic stem cell transplantation.
Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010601
Title: Combination chemotherapy and rituximab.
Journal: Anti-cancer drugs 20010601
Title: Nucleoside analogues in the treatment of haematological malignancies.
Journal: Expert opinion on pharmacotherapy 20010601
Title: Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
Journal: Expert opinion on pharmacotherapy 20010601
Title: Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens.
Journal: Leukemia & lymphoma 20010601
Title: Novel treatment strategies in chronic lymphocytic leukemia.
Journal: Current oncology reports 20010501
Title: Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia.
Journal: Journal of clinical pathology 20010501
Title: Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis.
Journal: Pharmacotherapy 20010501
Title: A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.
Journal: The British journal of dermatology 20010501
Title: Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20010501
Title: [Molecular biology examination in chronic lymphocytic leukemia].
Journal: Orvosi hetilap 20010422
Title: Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415
Title: Fludarabine for chronic lymphocytic leukemia.
Journal: The New England journal of medicine 20010412
Title: Fludarabine for chronic lymphocytic leukemia.
Journal: The New England journal of medicine 20010412
Title: Fludarabine for chronic lymphocytic leukemia.
Journal: The New England journal of medicine 20010412
Title: Fludarabine for chronic lymphocytic leukemia.
Journal: The New England journal of medicine 20010412
Title: Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol.
Journal: Blood 20010401
Title: Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Journal: American journal of hematology 20010401
Title: Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis.
Journal: Archives of disease in childhood 20010401
Title: Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
Journal: Leukemia & lymphoma 20010401
Title: [Mantle cell lymphoma].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20010401
Title: Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine.
Journal: Onkologie 20010401
Title: Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Journal: Bone marrow transplantation 20010401
Title: Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301
Title: Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Journal: Haematologica 20010301
Title: Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.
Journal: British journal of haematology 20010301
Title: New drug combinations for the treatment of murine AIDS and macrophage protection.
Journal: European journal of clinical investigation 20010301
Title: Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Journal: Experimental hematology 20010301
Title: Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.
Journal: Bone marrow transplantation 20010301
Title: Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.
Journal: Bone marrow transplantation 20010301
Title: Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20010301
Title: Reversal of fludarabine induced testicular damage in a patient with chronic lymphocytic leukaemia (CLL), by suppression of pituitary-testicular axis using gonadotrophin releasing hormone (GnRH).
Journal: Leukemia & lymphoma 20010301
Title: Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Journal: Blood 20010201
Title: Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment.
Journal: British journal of haematology 20010201
Title: Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation.
Journal: British journal of haematology 20010201
Title: A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment.
Journal: British journal of haematology 20010201
Title: Bilateral breast relapse in acute myelogenous leukemia.
Journal: Journal of pediatric hematology/oncology 20010201
Title: Reactivation of hepatitis B virus infection during cytotoxic chemotherapy.
Journal: The American journal of gastroenterology 20010201
Title: Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010201
Title: Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.
Journal: Leukemia & lymphoma 20010201
Title: Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.
Journal: Leukemia & lymphoma 20010201
Title: Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma.
Journal: Leukemia research 20010101
Title: Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Journal: Haematologica 20010101
Title: Red swollen nail folds and nail deformity as presenting findings in chronic lymphocytic leukaemia.
Journal: British journal of haematology 20010101
Title: Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells.
Journal: Leukemia 20010101
Title: A fludarabine-based conditioning regimen for severe aplastic anemia.
Journal: Bone marrow transplantation 20010101
Title: Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101
Title: Second allogeneic peripheral blood stem cell transplantation with fludarabine-based low-intensity conditioning regimen for relapsed myelodysplastic syndrome after allogeneic bone marrow transplantation.
Journal: International journal of hematology 20010101
Title: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Journal: Acta haematologica 20010101
Title: Treatment of 'poor risk' acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study.
Journal: Leukemia & lymphoma 20010101
Title: First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia.
Journal: Leukemia & lymphoma 20010101
Title: Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen.
Journal: Leukemia & lymphoma 20010101
Title: Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Journal: Leukemia & lymphoma 20010101
Title: A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Journal: Acta oncologica (Stockholm, Sweden) 20010101
Title: Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101
Title: Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma.
Journal: Leukemia & lymphoma 20010101
Title: Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
Journal: Leukemia & lymphoma 20010101
Title: Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies.
Journal: The oncologist 20010101
Title: Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.
Journal: European journal of dermatology : EJD 20010101
Title: Chronic lymphocytic leukaemia.
Journal: Clinical medicine (London, England) 20010101
Title: Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
Journal: Anticancer research 20010101
Title: [Lupus nephritis: treatments for today and tomorrow].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101
Title: [Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Journal: Duodecim; laaketieteellinen aikakauskirja 20010101
Title: In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Journal: Cytotherapy 20010101
Title: [Non-myeloablative therapy and allogeneic hematopoietic stem cell transplantation in hematologic malignancies].
Journal: Polskie Archiwum Medycyny Wewnetrznej 20010101
Title: Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Journal: The New England journal of medicine 20001214
Title: Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.
Journal: Leukemia & lymphoma 20000301
Title: Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
Journal: Blood 19981115
Title: Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
Journal: Hematology and cell therapy 19980601
Title: Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.
Journal: Anticancer research 19980101
Title: Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.
Journal: Leukemia 19941201
Title: Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
Journal: American journal of hematology 19941201
Title: Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Journal: Bone marrow transplantation 19930901
Title: Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
Journal: Leukemia & lymphoma 19930301
Title: Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.
Journal: Leukemia 19930301
Title: Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
Journal: Journal of medicinal chemistry 19920124
Title: In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
Journal: Molecular pharmacology 19820301
